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CHARACTERIZATION AND FUNCTIONAL SIGNIFICANCE OF Msc2p & 
Zrg17p, WHICH FORM A ZINC TRANSPORT COMPLEX IN THE 
ENDOPLASMIC RETICULUM OF SACCHAROMYCES CEREVISIAE 
 
Charissa D. Ellis 
Dr. David J. Eide, Dissertation Supervisor 
ABSTRACT 
 Zinc is an essential nutrient for all organisms because of the many 
important roles zinc plays in cells.  In particular are the structural and catalytic 
roles zinc plays in proteins.  To obtain zinc from their environment, cells use zinc 
transport proteins in their plasma membranes.  Eukaryotic cells must also use 
zinc transporters to supply zinc to their intracellular organelles, including those of 
the secretory pathway.  Members of the cation diffusion facilitator (CDF) family 
have been shown to transport heavy metals out of the cytoplasm of cells, and 
many eukaryotic CDF members transport zinc into intracellular compartments.  
All six currently known CDF members in the budding yeast Saccharomyces 
cerevisiae transport metals into intracellular organelles.  This study focuses on 
the characterization and function of two CDF members in yeast. 
 In chapter two, we show that zinc is required for endoplasmic reticulum 
(ER) function in S. cerevisiae.  Zinc deficiency in this yeast induces the unfolded 
protein response (UPR), a system normally activated by unfolded ER proteins.  
Msc2p, a member of the CDF family, was previously implicated in zinc 
homeostasis.  Our results indicate that Msc2p is one route of zinc entry into the 
ER.  Msc2p localizes to the ER when expressed at normal levels.  UPR induction 
in low zinc is exacerbated in an msc2 mutant.  Genetic and biochemical evidence 
xv 
indicate that this UPR induction is due to genuine ER dysfunction.  Notably, we 
found that ER-associated protein degradation (ERAD) is defective in zinc-limited 
msc2 mutants.  We also show that the vacuolar CDF proteins Zrc1p and Cot1p 
are other pathways of ER zinc acquisition.  Finally, zinc deficiency up-regulates 
the mammalian ER stress response, indicating a conserved requirement for zinc 
in ER function among eukaryotes. 
 In chapter three, we demonstrate a novel interaction between two CDF 
family members:  Msc2p and a newly recognized CDF family member in yeast, 
Zrg17p.  ZRG17 was previously identified as a zinc-regulated gene controlled by 
the zinc-responsive Zap1p transcription factor.  A zrg17 mutant exhibits the same 
zinc-suppressible phenotypes as an msc2 mutant, including an induction of the 
UPR in low zinc.  Zrg17p localizes to the ER and is regulated by zinc at the 
protein level.  Msc2p and Zrg17p physically interact, as determined by co-
immunoprecipitation.  Therefore, we propose that Msc2p and Zrg17p form a zinc 
transport complex in the ER membrane, supplying zinc to the ER to maintain the 
function of this compartment.  We also demonstrate that ZnT5 and ZnT6, the 
closest mammalian homologues of Msc2p and Zrg17p, functionally interact.  
These results indicate that interactions between CDF members may be a 
common phenomenon. 
 In summary, we demonstrate a novel interaction between two CDF 
proteins in yeast.  Msc2p and Zrg17p interact to form a complex in the ER.  The 
purpose of this complex is to transport zinc into the ER to maintain the proper 
function of this compartment.  These results in yeast are reflected in mammalian 
xvi 
cells, suggesting that all eukaryotes require zinc for ER function, and that the 
interaction between CDF members is a universal phenomenon. 
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CHAPTER 1 
 
INTRODUCTION 
 
Charissa D. Ellis 
 
Department of Biochemistry, University of Missouri, Columbia, MO  65211 
2 
Overview 
 This dissertation details the characterization and functional importance of 
the zinc transport proteins Msc2p and Zrg17p in the endoplasmic reticulum (ER) 
of the budding yeast Saccharomyces cerevisiae.  To have a better understanding 
of the research presented on these transport proteins, this chapter introduces 
important concepts about zinc and zinc transporters.  First, we outline the 
essentiality of zinc and the many roles zinc plays in cells.  This leads to the 
examination of proteins that require zinc transporters, specifically those in the 
secretory pathway.  The current model of zinc transport and regulation in yeast is 
discussed, followed by an overview of the different families of zinc transporters.  
Lastly, we focus on one specific family of zinc transporters, the cation diffusion 
facilitator (CDF) family, of which Msc2p and Zrg17p are members. 
 
Essentiality and roles of zinc 
All life on earth requires zinc.  In fact, zinc is the second most abundant 
trace metal found in eukaryotic organisms, second only to iron (1).  Additionally, 
Coleman claims that if one were to subtract the iron in hemoglobin, zinc would 
become the most abundant trace metal in the human body (1)!  The reason for 
this widespread use of zinc may be due to the unique properties of zinc itself.  
First, unlike iron or copper which undergo Fenton chemistry, zinc is not a redox 
active metal, so there is no potential damage to DNA or proteins due to free 
radical cascades (2, 3).  Second, zinc is a borderline Lewis acid, which allows it 
to interact strongly with several different ligands.  In particular, zinc favors binding 
3 
to the following ligands in proteins:  the sulfur from cysteine, the nitrogen from 
histidine, and the oxygen from aspartate, glutamate, and water (2).  Third, zinc 
can undergo ligand exchange reactions rather quickly, making it kinetically labile 
(2).  Finally, while zinc is most often bound to four ligands in a tetrahedral 
coordination geometry, it exhibits flexibility in the types of ligand coordination 
geometries it accepts (3, 4). 
These properties of zinc allow it to play many important roles in cells.  In 
particular are the structural and catalytic roles zinc plays in proteins.  More than 
ten different classes of structural zinc-binding domains have been identified (2).  
Perhaps the best known of these is the zinc finger.  In the classical C2H2 type 
zinc finger, a span of ~30 amino acids folds around a single zinc ion, which is 
coordinately bound by two cysteine residues on a beta sheet and two histidine 
residues on an alpha helix (5).  This type of zinc finger was originally discovered 
in the TFIIIA transcription factor in Xenopus laevis (6).  Now, with the sequencing 
of the human genome, Venter et al. found 4500 C2H2 type zinc finger domains in 
564 human proteins:  approximately 1-2% of the human genome (7)!  In fact, zinc 
finger domains are the most abundant DNA binding motif in eukaryotic 
transcription factors (2).  The alpha helical portion of the zinc finger is able to fit 
into the major groove of a DNA double helix, allowing the amino acid residues 
there to make site-specific interactions with DNA bases (5). 
Other zinc structural domains bind two or more atoms of zinc.  RING 
finger domains consist of eight amino acid residues (mostly cysteines) that form 
two overlapping zinc binding sites (8).  The zinc cluster in the Gal4p DNA-binding 
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domain of S. cerevisiae has two zinc ions bound by six cysteine residues (9).  A 
last example is the zinc cluster domains found in mammalian metallothioneins.  
These metallothioneins are small 62 amino acid proteins which bind zinc in two 
separate metal clusters:  Zn4Cys11 and Zn3Cys9 (3). 
In terms of a catalytic role, zinc is found in the active site of more than 300 
different enzymes in all six enzyme classes (4).  Zinc is the only metal found in all 
enzyme classes (4).  The different types of catalysis performed by zinc 
metalloenzymes is determined by the ligands coordinating the zinc in the active 
site, as well as the spacing between these ligands (4).  Unlike structural zinc 
sites, catalytic zinc is bound to three amino acid ligands in all active sites, the 
most common ligand being histidine.  The fourth ligand is always water (3, 4).  
This being the case, often zinc acts as an electrophilic catalyst to activate the 
water molecule (3, 8).  For example, in carbonic anhydrase, the zinc atom 
promotes the deprotonation of water to a hydroxide ion, which then attacks the 
carbon on carbon dioxide, generating bicarbonate (10).  Alternatively, zinc plays 
a different role in the active site of alcohol dehydrogenase.  Here, zinc functions 
to coordinate the alcohol substrate and keep it in the appropriate conformation so 
that a hydride (H-) can be transferred from the alcohol to the cofactor NAD+, 
thereby converting the alcohol to acetaldehyde (10). 
Besides these roles in proteins, zinc may potentially play a role as a 
neuromodulator in the brains of mammals.  Zinc is stored in synaptic vesicles in 
the mossy fiber projections of neurons in the hippocampus and in neurons of the 
cerebral cortex (11, 12).  Upon high-frequency stimulation, these vesicles 
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exocytose, releasing their zinc into the synaptic cleft between neurons (13, 14).  
Here, zinc is proposed to modulate the activity of various receptors.  The 
activities of ionotropic glutamate receptors, such as the N-methyl-D-aspartate 
(NMDA) receptors, and gamma-aminobutyric acid (GABA) receptors have been 
shown to be inhibited by zinc in vitro (15, 16). 
To further demonstrate the essentiality of zinc in humans is the hereditary 
zinc deficiency disease acrodermatitis enteropathica (AE).  People suffering from 
AE show typical characteristics of nutritional zinc deficiency, including alopecia 
(hair loss), dermatitis, low serum zinc and alkaline phosphatase levels, and 
mental disorders (17, 18).  Patients can be successfully treated with zinc 
supplementation (18).  The cause of AE has recently been attributed to mutations 
in a gene encoding a zinc transport protein, hZip4 (17, 19).  The hZip4 protein 
was localized to the apical membrane of intestinal enterocytes, and has been 
postulated to take up zinc from the diet (17).  Therefore, it can be seen that 
mutations rendering the hZip4 transporter ineffective would result in zinc 
deficiency, and hence the AE disease. 
 
The need for zinc transport proteins 
The many roles of zinc demonstrate the need for zinc in cells.  However, 
since zinc is an ion, it cannot merely pass through a lipid bilayer membrane.  
Therefore, cells require zinc transporters in their plasma membranes to obtain 
zinc from their extracellular environment.  Eukaryotic cells also require zinc 
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transporters in the membranes of their intracellular organelles to supply zinc to 
those compartments. 
There are many zinc metalloproteins that reside in or move through the 
secretory pathway that require zinc.  In pancreatic beta cells, the maturation of 
proinsulin to insulin granules requires zinc.  Early in the secretory pathway in the 
ER and/or Golgi, proinsulin binds zinc to form homohexamers (20, 21).  Later in 
the secretory pathway, insulin granule core formation is also facilitated by zinc 
(20).  Matrix metalloproteases are secreted zinc-containing enzymes that 
dissolve extracellular matrix for cell migration, invasion, tissue resorption and 
remodeling, and development (22, 23).  These proteins would need to acquire 
zinc in the secretory pathway in order to be functional.  Killer T cells display a 
large variety of antigen peptides on their cell surface through major 
histocompatibility complex (MHC) class I molecules.  A lumenal ER zinc 
metalloenzyme known as the ER-associated aminopeptidase (ERAAP) is 
responsible for processing some of these peptides by cleaving the N-terminal 
amino acid residues (24, 25).  Resident ER transferase enzymes responsible for 
attaching phosphoethanolamine groups to glycosylphosphatidylinositol- (GPI-) 
anchors are zinc-requiring enzymes (26, 27).  Lastly, the Scj1p chaperone 
protein found in the ER of S. cerevisiae is a type I homologue of the Escherichia 
coli DnaJ (Hsp40) protein (28, 29).  All DnaJ type I homologues contain two zinc 
binding centers, which are necessary for the chaperone activity of these proteins 
(30).  Since all of these (and many other) proteins described above need to 
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acquire zinc, they illustrate the need for zinc transporters in the ER and other 
organelles of the secretory pathway. 
 
Zinc transport and regulation in Saccharomyces cerevisiae 
The budding yeast, S. cerevisiae, has been an excellent model to 
elucidate and understand the zinc transport proteins that supply zinc to the cell 
and its intracellular organelles, as well as how these proteins are regulated.  
Initially, zinc enters the yeast cell through one of several transporters on the 
plasma membrane (Figure 1.1).  Zrt1p is a high affinity zinc transporter 
responsible for most of the zinc coming into the yeast cell in times of zinc 
deficiency (31).  Zrt2p and Fet4p are low affinity transporters that supply zinc 
under more moderate conditions of zinc deficiency (32, 33).  The genes for all 
three of these proteins are up-regulated in zinc-limiting conditions by the zinc-
regulated transcription factor, Zap1p (34).  Zap1p recognizes an eleven base pair 
consensus sequence, a zinc-responsive element or ZRE, found in one or more 
copies in the promoters of each of its target genes (35, 36).  Lyons et al. 
determined there to be at least 46 Zap1p targets in the yeast genome (36). 
Two other Zap1p targets of note are ZRT3 and ZRC1, which encode zinc 
transporters that localize to the membrane of the vacuole.  The vacuole is the 
major site of zinc storage in yeast.  In zinc deficiency, Zrt3p mobilizes vacuolar 
zinc stores so that they may used by the rest of the cell (37).  However, when 
cytosolic zinc levels rise, Zrc1p, aided by Cot1p, pumps zinc into the vacuole for 
storage or detoxification (38).  The purpose of the up-regulation of ZRC1 in zinc 
8 
Figure 1.1.  Current model of zinc transport and regulation in Saccharomyces 
cerevisiae.  Plasma membrane transporters Zrt1p, Zrt2p, and Fet4p transport 
zinc into the cytoplasm.  Zrc1p and Cot1p pump zinc into the vacuole for storage, 
while Zrt3p pumps zinc out of the vacuole to mobilize zinc stores.  Msc2p and 
Zrg17p transport zinc into the ER and are discussed in Chapters 2 and 3, 
respectively.  Zap1p is a zinc-regulated transcriptional activator that up-regulates 
genes in zinc deficiency, including the genes that encode all of the above 
transporters except Cot1p and Msc2p. 
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deficiency may be a pro-active response, so that when the cell shifts from a zinc-
deficient to a zinc-replete environment, the sudden influx of zinc into the cytosol 
may be quickly pumped into the vacuole for detoxification (39). 
 
Classes of zinc transport proteins 
Zinc transport proteins are found in five classes.  Bacteria express 
proteins in all five classes, while yeast and mammalian cells express only two of 
these families.  The resistance nodulation cell division (RND) family is only found 
in a few gram-negative bacteria.  Members of this family, such as the CzcCBA 
system in Ralstonia metallidurans CH34 (40), export zinc across both the 
cytoplasmic and outer membranes of the bacterial cell (41).  Members of the 
ATP-binding cassette (ABC) family that have been shown to transport zinc are 
also only found in bacteria.  ABC transporters are primary transporters that bind 
and hydrolyze ATP to transport substrate across the membrane (42).  In E. coli, 
the ZnuABC system consists of three proteins that function as an ABC 
transporting complex responsible for high-affinity zinc uptake (43).  Zinc-
transporting P-type ATPases have been found in both prokaryotes and plants.  
P-type ATPases, like ABC transporters, are also primary transporters that utilize 
the energy from ATP hydrolysis to transport substrate.  However, P-type 
ATPases also undergo cycles of binding and phosphorylation events, including 
substrate binding, ATP binding, phosphorylation, ion release, and 
dephosphorylation (44).  The E. coli ZntA P-type ATPase transports zinc out of 
the cell (45, 46), and the Arabidopsis thaliana Hma2 and Hma4 proteins appear 
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to be involved with the export of zinc from root cells into the inner vascular (xylem 
and phloem) tissue (47). 
Zinc transport in yeast and mammalian cells is carried out exclusively by 
members of the Zrt-, Irt-like protein (ZIP) and cation diffusion facilitator (CDF) 
families.  The ZIP family is named after the first identified members of this family:  
the Zrt1p and Zrt2p zinc uptake transporters in S. cerevisiae (31, 32) and the 
Irt1p iron uptake transporter in A. thaliana (48).  This family now has over 90 
members in both prokaryotes and eukaryotes (49), including ZupT in E. coli (50), 
Zip1-4 in A. thaliana (51), ZnT1 in the metal hyperaccumulator plant Thlaspi 
caerulescens (52), GmZip1 in soybean (53), and hZip1-14 in humans (54), 
including the previously mentioned hZip4 protein implicated in AE disease.  Most 
members of this family have eight transmembrane domains (TMs) and a 
histidine-rich cytoplasmic loop between TMs three and four (54, 55).  The 
extracellular loop between TMs two and three may affect the metal specificity of 
the transporter (56).  The common function seen in all ZIP family members is 
transporting metals, usually zinc, into the cytoplasm, either from the extracellular 
environment or from intracellular compartments (54).  The mechanism of this 
transport is not clearly understood, but is probably some kind of secondary 
transport, such as a symport or antiport mechanism with another ion (54). 
 
The cation diffusion facilitator (CDF) family 
While ZIP family members increase cytoplasmic zinc levels, CDF family 
members have the opposite function.  The overall conserved function seen in this 
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family is in transporting zinc (or other heavy metals) out of the cytoplasm, either 
into intracellular organelles or to the extracellular environment (49, 57-59).  Like 
the ZIP family, the CDF family is a very large family of heavy metal ion 
transporters, with over 100 putative members in prokaryotes and eukaryotes 
(Figure 1.2) (49).  The first characterized members of this family were the CzcD 
protein found in R. metallidurans CH34 (60), and the Zrc1p protein of S. 
cerevisiae (61).  The CzcD protein and other bacterial members have been 
shown to transport cadmium, zinc, and cobalt (60, 62).  The MTP1 protein in the 
heavy metal hyperaccumulator plant Thlaspi goesingense has been shown to 
transport nickel (63).  Most, if not all, members of the CDF family are involved 
with zinc transport.  Most CDF proteins have six transmembrane domains, and 
the eukaryotic members have a histidine-rich cytoplasmic loop between TMs four 
and five (59).  This loop may play a role in the metal-specificity of the transporter 
(59, 63). 
The mechanism of transport for CDF members has been determined for a 
few family members.  Both the CzcD protein in Bacillus subtilis and the ZitB 
protein in E. coli were shown to exhibit antiport mechanisms of transport.  They 
both exchanged the efflux of zinc for the influx of potassium ions or protons (62, 
64).  Similarly, the Zrc1p protein in yeast was shown to require the proton 
gradient derived from the vacuolar H+-ATPase and utilize a H+/Zn2+ antiport 
mechanism to transport zinc into the vacuole (38).  Despite only these three 
examples, since both prokaryotic and eukaryotic proteins utilize an antiport 
mechanism, this is probably the overall method of transport for the CDF family.
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Figure 1.2.  Dendrogram of the CDF family.  This dendrogram is taken from 
reference (49); however, it has been modified to account for up-dated information 
in the literature and in the NCBI nonredundant protein database.  Subfamily I 
contains mostly prokaryotic proteins, while subfamilies II and III contain mostly 
eukaryotic proteins.  Interestingly, the yeast members fall into all three 
subfamilies:  Mmt1p and Mmt2p in subfamily I, Msc2p in subfamily II, and Zrc1p 
and Cot1p in subfamily III.  (Zrg17p was not known to be a CDF member when 
this dendrogram was generated, but would probably fall into subfamily III with 
ZnT6.) 
14 
 
 
 
Mmt2p 
Mmt1p 
Msc2p 
Zrc1p 
Cot1p 
15 
Perhaps the best-characterized members of this family are the 
mammalian ZnT proteins.  These proteins demonstrate the wide variety of 
subcellular localizations and functional roles of CDF proteins.  Ten ZnT proteins 
have been identified (65), and of these, ZnT1-8 have been characterized, all 
demonstrating involvement with zinc homeostasis (57).  ZnT1 is the only ZnT 
protein that has been localized to the plasma membrane.  It is responsible for 
pumping zinc into the extracellular environment to prevent a toxic build up of zinc 
in the cytosol (66, 67).  Consistent with this is the finding that the Znt1 gene is a 
target of MTF1, the transcription factor that up-regulates metallothionein genes in 
times of zinc sufficiency (68).  However, ZnT1 is also found on the basolateral 
membrane of intestinal enterocytes and could be involved in the transfer of zinc 
from the diet to the bloodstream (69, 70).  Interestingly, Znt1 knock-out mice are 
embryonically lethal; however, the reason for this essentiality is unclear (71). 
ZnT2 has a similar function to ZnT1 in detoxifying the cytosol, but by 
putting zinc into an endosomal compartment (72).  ZnT2 may have a similar role 
as Zrc1p in yeast by putting zinc into a compartment for storage.  ZnT3 has been 
localized to synaptic vesicles in neurons of the hippocampus, and is responsible 
for transporting zinc into these vesicles so zinc can act as a neuromodulator in 
the brain (73, 74).  ZNT4 was identified as the gene that when mutated resulted 
in the lethal milk mouse phenotype.  Pups born to mice with these mutations died 
due to a lack of zinc in the milk (75).  Consistent with this, ZnT4 has been 
localized to intracellular/secretory vesicles in mammary tissue (76, 77). 
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ZnT5-7 have all been localized to the Golgi apparatus, but have different 
tissue distributions, and ZnT8 has been localized to intracellular secretory 
vesicles.  The exact roles of these four proteins in the secretory pathway are still 
to be determined.  Both ZnT5 and ZnT8 have high expression in pancreatic beta 
cells and have been suggested to be involved with zinc transport into insulin 
secretory granules (78, 79).  Besides the pancreas, analysis of expressed 
sequence tags (ESTs) suggest that ZnT5 is ubiquitously expressed in human 
tissues (65).  ZnT5 belongs to a small subset of the CDF family in which these 
proteins contain between 12 and 15 transmembrane domains instead of six.  The 
last six TMs are the most homologous to other members of the family (78).  ZnT6 
and ZnT7 have both been implicated in supplying zinc to proteins of the trans-
Golgi network.  The tissue distribution of ZnT6 and ZnT7 vary widely, as 
determined by different groups.  ZnT6 mRNA and protein are consistently seen in 
lung, small intestine, kidney, and brain (65, 80).  ZnT7 mRNA, while seen only in 
low levels, is expressed mostly in liver, prostate, small intestine, spleen, eye, and 
colon (65, 81). 
Prior to the work presented here, six CDF family members had been 
identified in yeast:  one in Schizosaccharomyces pombe and five in 
Saccharomyces cerevisiae.  The Zhf1 protein in S. pombe was localized to the 
endoplasmic reticulum, and pumps zinc into this compartment for storage (82, 
83).  Mmt1p and Mmt2p of S. cerevisiae were localized to the inner mitochondrial 
membrane and have been implicated with mitochondrial iron uptake (84), though 
their exact role is not clearly understood (85).  Zrc1p and Cot1p were originally 
17 
discovered by their ability to give tolerance to zinc and cobalt, respectively (61, 
86).  Both localize to the membrane of vacuole and transport zinc into this 
compartment (38).  The last member in yeast is Msc2p.  This protein is described 
in detail in chapter two. 
 
Characterization and functional importance of ER zinc transporters in yeast 
Zinc transporters in the secretory pathway, including those in the 
membrane of the ER, are largely unknown.  For those that have been identified, 
such as the mammalian ZnT5-8 proteins, the exact role of these transporters and 
their downstream effects in the secretory pathway are also unknown.  Given the 
different classes of zinc transporters, those that would pump zinc into the 
secretory pathway are most likely CDF family members.  The focus of this 
dissertation is on the characterization and functional importance of two CDF 
members that transport zinc into the ER of yeast.  The next chapter characterizes 
Msc2p.  Msc2p was found to be important for zinc transport into the ER to 
maintain proper function of this compartment.  The third chapter characterizes 
Zrg17p.  Zrg17p is a newly identified CDF member that was found to physically 
interact with Msc2p, and together, they may form a complex to transport zinc into 
the ER.  The last chapter discusses the implications of an Msc2p-Zrg17p zinc 
transport complex and the future studies of this project.
18 
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ABSTRACT 
In this report, we show that zinc is required for endoplasmic reticulum (ER) 
function in Saccharomyces cerevisiae.  Zinc deficiency in this yeast induces the 
unfolded protein response (UPR), a system normally activated by unfolded ER 
proteins.  Msc2p, a member of the cation diffusion facilitator (CDF) family of 
metal ion transporters, was previously implicated in zinc homeostasis.  Our 
results indicate that Msc2p is one route of zinc entry into the ER.  Msc2p 
localizes to the ER when expressed at normal levels.  UPR induction in low zinc 
is exacerbated in an msc2 mutant.  Genetic and biochemical evidence indicate 
that this UPR induction is due to genuine ER dysfunction.  Notably, we found that 
ER-associated protein degradation (ERAD) is defective in zinc-limited msc2 
mutants.  We also show that the vacuolar CDF proteins Zrc1p and Cot1p are 
other pathways of ER zinc acquisition.  Finally, zinc deficiency up-regulates the 
mammalian ER stress response indicating a conserved requirement for zinc in 
ER function among eukaryotes. 
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INTRODUCTION 
Zinc is an important cofactor for many proteins that reside in or pass 
through organelles of the secretory system.  For example, packaging of insulin in 
secretory granules of pancreatic β-cells is dependent on Zn2+ (1, 2).  Matrix 
metalloproteases are Zn2+-requiring enzymes that are secreted by cells to modify 
the extracellular matrix during development and tumor cell metastasis (3).  These 
proteins acquire zinc at an early point in the secretory pathway (4, 5).  Addition of 
phosphoethanolamine groups to glycosylphosphatidylinositol- (GPI-) anchors 
requires Zn2+-dependent enzymes in the endoplasmic reticulum (ER) (6-8).  As a 
last example, some protein chaperones homologous to Escherichia coli DnaJ, 
like the ER-localized Scj1p of Saccharomyces cerevisiae, likely require Zn2+ to 
function in protein folding and in the degradation of misfolded proteins by quality 
control mechanisms (9-12).  These many requirements for Zn2+ in the secretory 
pathway highlight the need for zinc transporters to deliver the metal to those 
organelles.  Despite the importance of these various zinc-dependent processes 
in normal cell function and disease states such as cancer, the transport proteins 
responsible for zinc delivery have not yet been identified. 
Members of the cation diffusion facilitator (CDF) family of transport 
proteins are likely candidates to transport Zn2+ into the secretory pathway.  CDF 
proteins play conserved roles in transporting Zn2+ from the cytosol into organelles 
or out of the cell in many organisms (13-16).  In E. coli, for example, the ZitB 
CDF protein transports excess zinc from the cytosol to the extracellular 
environment (17).  In mammals, ZnT1 similarly transports excess cytosolic zinc 
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while ZnT2 may detoxify the metal by sequestering it in the late endosome (18-
20).  Three mammalian CDF proteins implicated in Zn2+ transport into the 
secretory pathway are ZnT5, ZnT6, and ZnT7, each of which having been 
localized to the Golgi apparatus (21-23).  The functional roles of these proteins 
are not yet clear.   
 We have learned much about zinc homeostasis from studies of the yeast 
S. cerevisiae.  In this yeast, zinc uptake is mediated by the high affinity Zrt1p 
transporter and the lower affinity Zrt2p and Fet4p proteins (24-26).  The genes 
encoding these transporters are controlled by the Zap1p transcriptional activator 
protein (27).  Zap1p is active in zinc-limited cells, and its activity is repressed in 
zinc-replete cells.  Zap1p binds to one or more zinc-responsive elements (ZREs) 
in the promoters of its target genes (28).   
Zinc storage and detoxification in S. cerevisiae is mediated by the 
vacuole.  The Zrc1p and Cot1p proteins, both members of the CDF family, are 
responsible for zinc transport into the vacuole (29-32).  Two other CDF proteins, 
Mmt1p and Mmt2p, have been implicated in iron transport in the mitochondria 
(33).  The fifth yeast CDF member, and the subject of this report, is Msc2p.  
Msc2p was first identified in a screen for mutations with altered frequencies of 
meiotic sister chromatid exchange (34).  However, the link between DNA 
recombination and the MSC2 gene is unclear; the effects on recombination are 
allele-specific and not observed in a full msc2 deletion mutant (35).  A more 
recent study of Msc2p suggested that it played some role in zinc metabolism 
(36).  An msc2 mutant grew poorly on respired carbon sources at elevated 
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temperatures and had an abnormally large cell size.  Both of these phenotypes 
were suppressed by addition of excess zinc.  In this report, we demonstrate that 
Msc2p is an ER membrane protein whose role is to maintain proper function of 
the ER.  Our results indicate that key processes in the ER require Zn2+ and that 
Msc2p is involved in supplying Zn2+ to this compartment.
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EXPERIMENTIAL PROCEDURES 
Yeast strains and growth conditions 
Media used were YPD, SD, YPGE, and LZM as described previously (37).  
Strains used are described in Table 2.1. Yeast deletion mutants were obtained 
from Research Genetics.  To generate several strains, the KanMX cassette with 
500 bp flanking the gene to be mutated was amplified by PCR from the 
appropriate mutant.  The PCR fragment was then transformed into the 
appropriate recipient strain.  This method was used to generate strains CEY3-8, 
CEY27-29, CM158, CM160, CM162, and CM164.  CM158 and CM164 were 
crossed to generate CEY25, and CM160 and CM162 were crossed to generate 
CEY26.  CEY13 and CEY17 are haploid segregants of CEY25 and CEY26, 
respectively.  CEY8 and DY150 were crossed to generate CEY24.  CEY19-23 
and CEY27-29 are haploid segregants of CEY24.  
 
Yeast Plasmids 
pDg2L (ZRE-lacZ) (30), pHYC3 (HIS4-lacZ) (38), and pMCZ-Y (UPRE-
lacZ) (39) were described previously.  pSN222 (Kex2p-HA) was a gift of Steve 
Nothwehr (University of Missouri).  pRK315 (Pma1p-HA) was a gift of Ralf Kölling 
(Düsseldorf, Germany).  pDN436 (CPY*-HA) was a gift of Davis Ng 
(Pennsylvania State University).  pGEV-TRP1 was co-transformed with pRK315 
so that Pma1p-HA expression levels could be controlled by β-estradiol (Sigma) 
(10-7M) addition (40).  pMCZ-YL was constructed by exchanging the URA3 gene 
on pMCZ-Y with the LEU2 gene by marker swapping (41).  pDN436U was  
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Table 2.1.  Strains used in this study 
________________________________________________________________ 
 
Strain                    Genotype         Reference 
________________________________________________________________ 
 
DY150     MATa ade2 can1 his3 leu2 trp1 ura3     (36) 
DY150 msc2     DY150 msc2::HIS3       (36) 
DY1457     MATα ade6 can1 his3 leu2 trp1 ura3     (24) 
ZHY1      DY1457 zrt1::LEU2       (24) 
CM100     MATα can1 his3 leu2 trp1 ura3      (30) 
CM102     CM100 zrc1::HIS3       (30) 
CM103     CM100 cot1::URA3       (30) 
CM104     CM100 zrc1::HIS3 cot1::URA3      (30) 
CM158     CM100 scj1::KanMX          This Work 
CM160     CM100 jem1::KanMX       " 
CM162     DY150 msc2::HIS3 scj1::KanMX     " 
CM164     DY150 msc2::HIS3 jem1::KanMX     " 
CEY3      DY150 ire1::KanMX       " 
CEY4      DY150 hac1::KanMX       " 
CEY5      DY150 msc2::HIS3 ire1::KanMX     " 
CEY6      DY150 msc2::HIS3 hac1::KanMX     " 
CEY7      CM100 msc2::KanMX       " 
CEY8, 27-29     CM100 msc2::KanMX zrc1::HIS3 cot1::URA3   " 
CEY13     DY150 jem1::KanMX       " 
CEY17     DY150 jem1::KanMX scj1::KanMX     " 
CEY19-21      CM100 msc2::KanMX zrc1::HIS3     " 
CEY22, 23     CM100 msc2::KanMX cot1::URA3     " 
CEY24     DY150 X CEY8 diploid       " 
      MATa/α can1/can1 ade2/ADE2 his3/his3 
leu2/leu2 trp1/trp1 ura3/ura3 msc2::KanMX 
zrc1::HIS3 cot1::URA3 
CEY25     CM158 X CM164 diploid      " 
      MATa/α can1/can1 ade2/ADE2 ade6/ADE6 
his3/his3 leu2/leu2 trp1/trp1 ura3/ura3 
msc2::HIS3 jem1::KanMX scj1::KanMX 
CEY26     CM160 X CM162 diploid      " 
      MATa/α can1/can1 ade2/ADE2 ade6/ADE6 
his3/his3 leu2/leu2 trp1/trp1 ura3/ura3 
msc2::HIS3 jem1::KanMX scj1::KanMX 
________________________________________________________________ 
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constructed by exchanging the LEU2 gene on pDN436 with the URA3 gene (41).  
To generate pMSC2, the MSC2 ORF plus ~500 bp of flanking DNA was amplified 
by PCR from genomic DNA and inserted into EcoR1-, Pst1-digested pFL38 by 
homologous recombination (42).  Msc2p function was confirmed by 
complementing the msc2 mutant.  To generate pMSC2HA, the MSC2 ORF plus 
~500 bp promoter and lacking the stop codon was PCR amplified from genomic 
DNA and inserted into YCpZRC1-HA (32) by homologous recombination.  The 
resulting plasmid has the MSC2 promoter and ORF followed by three HA tags.  
The plasmid was confirmed by complementing the msc2 mutant.  To generate 
pHAC1, the HAC1 ORF plus ~1300 bp upstream and ~900 bp downstream 
flanking DNA were amplified from genomic DNA and inserted into Sac1-, Xma1-
digested pRS315 via homologous recombination.  To generate pHAC1i, overlap 
PCR was used to generate the HAC1 ORF (plus flanking DNA as above) without 
the intron (43).  This fragment was then inserted into pRS315 via homologous 
recombination.  DNA sequencing confirmed the lack of the intron. 
 
Yeast β-galactosidase assays 
β-galactosidase assays were performed on protein extracts (44) and 
specific activity was normalized to protein content. 
 
Subcellular fractionation and immunoblotting 
Subcellular fractionation was done largely as described by Roberg et al. 
(45).  Lysates were fractionated on 20-60% sucrose gradients prepared with 10 
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mM EDTA (-Mg) or with 2 mM MgSO4 (+Mg).  Immunoblots were done by 
standard techniques (46).  Blots were visualized with ECL (Amersham 
Biosciences), and band quantitation was performed using NIH Image 1.61.  
Antibodies used were mouse anti-HA (12CA5, Roche), rabbit anti-HA (Sigma), 
mouse anti-Dpm1p (Molecular Probes), mouse anti-Pgk1p (Molecular Probes), 
goat anti-mouse HRP-conjugated secondary (Pierce), and goat anti-rabbit HRP-
conjugated secondary (Pierce). 
 
Assay of ER-associated degradation (ERAD) 
Yeast were grown in 200 mL cultures to an OD600 = ~ 0.5.  Cells were 
harvested and resuspended in 100 mL fresh medium to a final OD600 = ~ 1.0.  
Cells were grown 30 minutes, then cycloheximide (Sigma) was added to a final 
concentration of 100 µg/mL.  Five mL aliquots of cells were removed at each time 
point to tubes containing NaN3 to a final concentration of 10 mM.  After the last 
time point, the cells were collected by centrifugation and washed once with cold 
buffer containing 10 mM NaN3, 1 mM EDTA.  Cells were resuspended in 1 mL of 
the same buffer and transferred to microfuge tubes.  Cells were pelleted and 
resuspended in 200 µL cold protein extraction buffer [10 mM Tris-Cl, pH 8, 25 
mM ammonium acetate, 1 mM EDTA, 1 mM PMSF, 10% Trichloroacetic acid 
(Sigma), yeast proteinase inhibitor cocktail (complete mini EDTA-free pellets, 
Roche)].  An equal volume of glass beads was added and the tubes were 
vortexed 5 times for 1 min, with 1 min on ice between pulses.  Lysates were 
transferred to fresh tubes.  Another 500 µL protein extraction buffer was added to 
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the glass beads, vortexed 1 min, and then pooled with the previous lysates.  
Lysates were centrifuged at 14,000 X g at 4oC for 10 min.  The supernatant was 
removed and discarded.  The pellets were resuspended in 120 µL buffer I (100 
mM Tris base, 3% SDS, 1 mM PMSF), then boiled for 5 min.  Insoluble debris 
was pelleted by centrifuging 5 min at 15,800 x g.  The supernatant was 
transferred to new tubes and protein concentrations were measured using the 
BIO-RAD DC protein kit.  Ten µg of protein were loaded per lane when analyzed 
by immunoblotting. 
 
Cell culture, transient transfection, mammalian plasmids and assays 
HeLa cells were cultured in DMEM (Invitrogen) plus 0.45% glucose under 
5% CO2.  All media contained 100 U/mL penicillin, 100 µg/mL streptomycin, 2 
mM L-glutamine and 100 µM MEM non-essential amino acids (Invitrogen) 
supplemented with 10% fetal bovine serum (Invitrogen).  p5xATF6GL3 was a gift 
of Ron Prywes (Columbia University), and contains five repeats of an ATF6 
binding site cloned into a minimal promoter preceding the firefly luciferase gene 
(47).  pSV-β-galactosidase control vector (Promega) was used as a control for 
transfection efficiency.  HeLa cells (~1.2 x 106) were seeded in 60 mm plates and 
transiently transfected using Lipofectamine 2000 (Invitrogen).  Both p5xATF6GL3 
and pSV-β-galactosidase plasmids were co-transfected in all experiments.  
Transfection efficiencies were typically 60%.  36-48 hours post-transfection, 
tunicamycin (Sigma), ZnCl2, or N,N,N´,N´-tetrakis-(2-
pyridylmethyl)ethylenediamine (TPEN) (Sigma) was added to the culture medium 
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at the indicated concentrations.  After treatment, the cells were washed 3 times 
with cold PBS.  To generate protein extracts and perform luciferase and β-
galactosidase assays, the Luciferase Assay System with Reporter Lysis Buffer 
(Promega) was used.  Luciferase activity was normalized to β-galactosidase 
activity as an internal control.
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RESULTS 
Zinc deficiency induces the Unfolded Protein Response 
Genome-wide cDNA microarray analysis of gene expression in S. 
cerevisiae indicated that many genes (458) are induced by zinc deficiency (48).  
This included 46 direct Zap1p targets and 412 genes up-regulated in a Zap1p-
independent fashion.  Induction of this latter group probably reflects indirect 
effects of zinc deficiency on cell function.  Among the genes indirectly affected by 
zinc were several involved in the Unfolded Protein Response (UPR).  The UPR is 
a response to the accumulation of unfolded proteins in the ER (49).  Figure 2.1A 
summarizes the microarray results for eight genes of the UPR (50) that were up-
regulated by two-fold or more in zinc-deficient wild type cells.  The up-regulation 
of these genes is independent of Zap1p; each showed similar induction by zinc 
deficiency in a zap1 mutant.  The UPR genes induced by zinc deficiency include 
ERO1, EUG1, and PDI1 (encoding proteins involved in protein disulfide 
isomerization), and FKB2 (encoding peptidyl-prolyl cis-trans isomerase).  In 
addition, JEM1, KAR2, LHS1, and SCJ1 were also up-regulated.  These genes 
encode ER chaperones that facilitate the translocation of misfolded ER proteins 
back to the cytosol for degradation in a process known as ER-associated 
degradation or ERAD.  
These data indicated that zinc deficiency up-regulates the UPR.  To 
confirm this hypothesis, we used a UPR-responsive reporter gene to assess the 
effect of zinc deficiency on UPR induction.  UPR target genes contain UPRE 
sequences in their promoters that confer this regulation.  A UPRE-lacZ reporter 
41 
Figure 2.1.  Zinc deficiency induces the unfolded protein response (UPR).  A, 
Microarray analysis of UPR target genes showing  2-fold induction in low zinc 
over high zinc in both wild type and zap1 mutant cells.  These data are from 
experiments previously described (48).  B, UPRE-lacZ activity in wild type (WT, 
DY1457) and the zrt1 mutant (ZHY1) over a range of zinc concentrations in LZM.  
LZM is zinc limiting because 1 mM EDTA is added to limit metal availability.  
Shown are representative data from two experiments.  C, HIS4-lacZ activity in 
DY1457 and ZHY1 in low (1 µM) and high (1000 µM) zinc in LZM.  Shown are 
representative data from two experiments.  The error bars indicate ± 1 S.D. 
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was highly induced in wild type cells grown in low zinc (e.g. LZM + 0.3 µM Zn) 
relative to zinc-replete cells (e.g. LZM + 1000 µM Zn) (Figure 2.1B).  These 
experiments were performed using LZM medium which is zinc-limiting due to 
addition of 1 mM EDTA.  Adding as little as 10 µM ZnCl2 to LZM was sufficient to 
repress UPRE-lacZ expression.  UPRE-lacZ induction in low zinc was also 
observed in zrt1 mutants defective for zinc uptake.  Because Zrt1p is the major 
zinc uptake transporter in yeast, the zrt1 mutant is zinc deficient when grown in 
LZM supplemented with  300 µM ZnCl2 (24).  The UPRE-lacZ reporter showed 
high levels of β-galactosidase activity in the zrt1 mutant over a wide range of zinc 
concentrations and was suppressed only by adding 1000 µM zinc to the medium 
(Figure 2.1B).  A HIS4-lacZ control reporter, which is not responsive to either 
zinc or unfolded proteins, showed high expression in both the wild type and the 
zrt1 mutant strains at all zinc concentrations (Figure 2.1C).  Therefore, the 
effects seen with the UPRE-lacZ reporter are specific UPR effects and not 
general effects on β-galactosidase activity.  The 2-fold increase in UPRE-lacZ 
expression observed between 30 and 100 µM zinc (Figure 2.1B) is similar to that 
seen with other promoters (e.g. HIS4-lacZ, Figure 2.1C) and probably reflects a 
general decrease in expression in severely zinc-deficient cells. 
 
Msc2p localizes to the endoplasmic reticulum 
Induction of the UPR in low zinc suggested that zinc transport into the 
lumen of the ER is required for ER function.  A transporter protein possibly 
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involved in delivering zinc into the ER is encoded by the MSC2 gene.  Previous 
studies suggested that Msc2p was localized to the endoplasmic reticulum.  
However, these experiments were done under conditions where Msc2p was 
overexpressed.  Because overexpression can result in protein mislocalization, 
the true intracellular location of Msc2p was unclear.  Therefore, we determined 
the localization of Msc2p when expressed from its own promoter on a low copy 
plasmid.  To aid detection of Msc2p, we generated an MSC2 allele with three 
hemagglutinin (HA) tags fused to its C-terminus.  Immunoblots detected only a 
single band near the predicted molecular mass of Msc2p (data not shown).  
Moreover, the epitope-tagged protein complemented the temperature-sensitive 
growth defect phenotype of an msc2 mutant strain indicating that it is functional.   
Attempts to determine the subcellular localization of Msc2p using 
immunofluorescence microscopy were inconclusive because the level of 
expression was too low.  Therefore, we used sucrose gradient fractionation to 
assess the distribution of Msc2p.  Protein extracts of wild type cells expressing 
HA-tagged Msc2p were separated on sucrose gradients.  After centrifugation, 
fractions were collected and analyzed by immunoblotting.  Previous reports have 
shown that the presence or absence of Mg2+ greatly alters the position of ER 
vesicles in the gradient (45).  Without added Mg2+, the ER co-fractionates with 
the Golgi apparatus in the middle fractions of the gradient.  However, in the 
presence of Mg2+, the ER localizes to the heavier fractions of the gradient, co-
fractionating with the plasma membrane.  This shift to heavier fractions is likely 
due to ribosomes remaining associated with the ER when Mg2+ is present.  If 
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Msc2p localizes to the ER, we predicted that the protein would show this Mg2+-
dependent shift in these gradients. 
 Kex2p is a Golgi marker protein and its fractionation, peaking around 
fraction 6 in the middle of the gradients (Figure 2.2), was unaffected by Mg2+.  A 
plasma membrane protein, Pma1p, also was largely unaffected by Mg2+ levels 
with its peak fractionation in the heaviest fractions of both gradients.  Dpm1p 
served as an ER marker.  Both Msc2p and Dpm1p showed the diagnostic ER 
Mg2+ shift, being found in the heavier fractions with Mg2+ and fractionating in the 
middle fractions without Mg2+.  Because Msc2p co-fractionates with an ER 
marker protein and shows the characteristic ER Mg2+ shift, these studies strongly 
support the localization of Msc2p to that compartment.  In the presence of Mg2+, 
some Msc2p was also found in lighter fractions that may correspond to the Golgi.  
Little Dpm1p was found in these lighter fractions. 
 
Mutation of MSC2 alters zinc homeostasis 
If Msc2p transports zinc into the ER lumen, we predicted that mutation of 
the MSC2 gene would alter homeostasis of cytosolic labile zinc.  A useful 
bioassay of this labile zinc is the Zap1p transcription factor which binds to zinc-
responsive elements (ZREs) in it target promoters.  Zap1p is active in zinc-limited 
cells and repressed by high zinc.  The zinc response curve of a ZRE-lacZ 
reporter in wild type cells is shown in Figure 2.3A.  If Msc2p transported zinc into 
the ER, we predicted that cytosolic zinc levels would increase in an msc2 mutant 
strain and repress Zap1p activity.  Consistent with this prediction, expression of 
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Figure 2.2.  Msc2p is localized to the endoplasmic reticulum.  Lysates were 
prepared from wild type (WT, DY150) cells expressing either pMSC2HA and 
pSN222 (Kex2p-HA) or pGEV-TRP1 and pRK315 (Pma1p-HA).  Extracts were 
layered onto sucrose gradients for subcellular fractionation.  Gradient fractions 
were subjected to immunoblotting and probed with anti-HA or anti-Dpm1p 
antibodies.  Fractions are numbered from 1 (heaviest) to 11 (lightest).  Shown 
are representative data from three experiments.  A, Plot of immunoblot band 
intensities from fractions prepared +Mg.  B, Plot of immunoblot band intensities 
from fractions processed -Mg.  The lines labeled ER, PM, and Golgi denote 
fractions containing  50% of the peak values for the corresponding marker 
protein. 
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Figure 2.3.  The msc2 mutant increases labile zinc levels.  A, ZRE-lacZ activity 
in wild type (WT, DY150) and the msc2 mutant (DY150 msc2) grown over a 
range of zinc concentrations in LZM.  Shown are representative data from five 
experiments.  B, HIS4-lacZ activity in wild type (WT, DY150) and the msc2 
mutant (DY150 msc2) in low (1 µM) and high (1000 µM) zinc in LZM.  Shown are 
representative data from five experiments.  The error bars indicate ± 1 S.D. 
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the ZRE-lacZ reporter was suppressed in msc2 cells grown in LZM + 0.3-10 µM 
ZnCl2 (Figure 2.3A).  Mutation of MSC2 did not decrease expression of the 
HIS4-lacZ reporter indicating that the effects of the msc2 mutation were specific 
to the ZRE-lacZ reporter (Figure 2.3B).  These results suggest that Msc2p 
transports zinc from the cytosol into the ER lumen.  
 
Effects of msc2 mutation on UPR induction 
If Msc2p transports zinc into the ER, we predicted that an msc2 mutant 
would increase induction of the UPR in low zinc relative to wild type cells.  This 
prediction was confirmed using the UPRE-lacZ reporter (Figure 2.4A).  While the 
wild type strain showed some induction of the UPR in low zinc, this up-regulation 
was substantially increased in the msc2 mutant strain.  These data suggest that 
a strain lacking MSC2 experiences greater ER stress when coupled with zinc 
deficiency.  To determine the metal specificity of this effect, we measured UPRE-
lacZ expression in an msc2 mutant under low zinc conditions when higher levels 
of zinc or other metals were added.  While as little as 10 µM zinc suppressed the 
UPR up-regulation, neither 10 µM nor 100 µM of Fe2+, Cu2+, Cd2+, Mn2+, Ni2+, or 
Co2+ greatly suppressed this up-regulation (Figure 2.4B).  Therefore, UPR 
induction in an msc2 mutant is a zinc-specific effect. 
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Figure 2.4.  The msc2 mutant increases UPR induction in zinc deficiency.  A, 
UPRE-lacZ activity in wild type (WT, DY150) and the msc2 mutant (DY150 msc2) 
over a range of zinc concentrations in LZM.  Shown are representative data from 
three experiments.  B, UPRE-lacZ activity in the msc2 mutant in LZM + 0.3 µM 
Zn.  The control condition (C) had no added metals.  Shown are representative 
data from two experiments.  The error bars indicate ± 1 S.D. 
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UPRE-lacZ induction by low zinc and msc2 mutation requires a functioning UPR 
signaling pathway 
UPR induction is achieved through a two-protein signaling pathway (for 
review, see (49)).  Ire1p is a transmembrane endoribonuclease protein that 
senses unfolded proteins in the ER.  Hac1p is the transcription factor that 
responds to that signal to increase expression of UPR target genes.  When Ire1p 
is activated by unfolded ER proteins, it cleaves an intron out of the HAC1 mRNA.  
The spliced HAC1 mRNA is translated into protein (Hac1pi), which then up-
regulates UPR target genes.  To verify that the induction of the UPR in an msc2 
mutant is dependent upon the Ire1p/Hac1p signaling pathway, we constructed 
msc2 ire1 and msc2 hac1 double mutants and analyzed their UPRE-lacZ activity.  
Dithiothreitol (DTT), a known inducer of the UPR because of its ability to disrupt 
disulfide bonds in ER proteins, did not cause UPRE-lacZ induction in ire1 and 
hac1 mutants in both the wild type and the msc2 mutant backgrounds (data not 
shown).  These mutants were also impaired for induction of the UPR in low zinc 
(Figure 2.5A).  These strains had no such effect on the control HIS4-lacZ 
reporter (data not shown).  Therefore, the induction of the UPR in low zinc in an 
msc2 mutant requires the full UPR signaling pathway. 
One can also envisage that an msc2 mutant may somehow hyperactivate 
Hac1pi independently of Ire1p.  To test this hypothesis, we introduced an intron-
less form of the HAC1 gene on a low copy plasmid (pHAC1i) into both wild type 
and msc2 mutant strains.  This plasmid-encoded Hac1pi does not rely upon Ire1p 
for its activation, and therefore causes constitutive UPR induction.  We predicted  
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Figure 2.5.  The msc2 mutant requires Ire1p and Hac1p for UPR induction.  A, 
UPRE-lacZ activity in wild type (WT, DY150), msc2 (DY150 msc2), ire1 (CEY3), 
hac1 (CEY4), msc2 ire1 (CEY5), and msc2 hac1 (CEY6) in low (1 µM) and high 
(1000 µM) zinc in LZM.  Shown are representative data from three experiments.  
B, UPRE-lacZ activity in wild type (WT, DY150) and the msc2 mutant (DY150 
msc2) expressing vector (pRS315) or pHAC1i in low (1 µM) zinc in LZM.  Shown 
are representative data from five experiments.  The error bars indicate ± 1 S.D. 
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that if the msc2 mutation made endogenous Hac1pi more active, it would have a 
similar effect on plasmid-encoded Hac1pi.  This was not the case.  Introduction of 
pHAC1i into wild type cells actually caused higher levels of UPRE-lacZ activity 
than was observed in the msc2 mutant (Figure 2.5B).  While the reason for the 
decreased expression in the mutant is not yet known, this result clearly 
demonstrates that the msc2 mutation does not increase Hac1pi activity 
independently of the UPR signaling pathway.   
 
Genetic and biochemical evidence for ER dysfunction in msc2 mutants 
The requirement for an intact Ire1p/Hac1p signaling pathway to induce the 
UPR in response to low zinc and loss of Msc2p function suggested that these 
factors perturbed ER function.  Further evidence supporting this conclusion came 
from the observation that msc2 ire1 and msc2 hac1 mutants exhibit a synthetic 
lethal growth phenotype.  msc2 single mutants grow poorly at 37°C on YP 
medium supplemented with glycerol and ethanol, two nonfermentable carbon 
sources, but show no such defect on medium supplemented with glucose (YPD), 
a fermentable carbon source (Figure 2.6).  Similarly, neither ire1 nor hac1 
mutants exhibit a growth defect on YPD at either 30°C or 37°C.  Combining these 
mutations, i.e. msc2 ire1 and msc2 hac1, resulted in a strong growth defect at 
37°C.  [The few colonies seen in the msc2 hac1 mutant at 37°C may be the 
result of spontaneously arising suppressor mutations.  More than 99% of the 
inoculated msc2 hac1 cells failed to grow at the elevated temperature.]  
Introducing the MSC2 or HAC1 genes on low copy plasmids (pMSC2, pHAC1) 
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Figure 2.6.  The msc2 mutant is synthetically lethal with ire1 and hac1 at 
elevated temperatures.  Yeast cells were grown in YPD or SD liquid medium 
overnight.  Cultures were diluted in fresh medium and 5 µL volumes (104 cells) 
were plated onto YPD plates, incubated at 30oC or 37oC, and photographed after 
2 days.  Wild type (WT, DY150), msc2 (DY150 msc2), ire1 (CEY3), hac1 (CEY4), 
msc2 ire1 (CEY5), and msc2 hac1 (CEY6) were grown and diluted in YPD prior 
to plating; msc2 hac1 + pMSC2 and msc2 hac1 + pHAC1 were grown and diluted 
in SD prior to plating. 
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back into the msc2 hac1 mutant restored growth at 37°C.  Thus, an msc2 mutant 
requires both Ire1p and Hac1p to survive at higher temperatures. 
 To further test the hypothesis that msc2 mutation and low zinc causes ER 
dysfunction, we examined one aspect of ER function, degradation of unfolded 
proteins through the ERAD pathway.  This particular aspect was addressed 
because Scj1p, an ER lumenal chaperone required for ERAD function, has two 
predicted zinc binding sites and is likely to require zinc for its activity.  The 
homologous E. coli DnaJ protein was shown to be zinc dependent (9, 10).  A 
useful assay of the ERAD system is to monitor the degradation of CPY*, a 
mutant carboxypeptidase Y protein that fails to fold properly and is degraded by 
ERAD (51).   Wild type and msc2 mutants were transformed with a plasmid 
expressing CPY* bearing an HA epitope tag (52).  The cells were grown in high 
or low zinc and then treated with cycloheximide to block further protein synthesis.  
Aliquots were removed periodically over 60 min for protein extraction and 
immunoblotting.  No difference was observed between wild type and msc2 
mutants in either growth condition (data not shown).  The UPR system induces 
expression of Scj1p and a second, partially redundant chaperone called Jem1p 
(Figure 2.1) (53).  While Scj1p is probably zinc-dependent, Jem1p lacks the zinc-
binding sites and is therefore likely to be zinc independent.  Therefore, increased 
expression of the Jem1p chaperone may compensate for the loss of zinc-
dependent Scj1p activity.  To test this hypothesis, we examined CPY* 
degradation in jem1 mutant cells lacking the zinc-independent chaperone.  CPY* 
turnover in a jem1 single mutant was rapid in both zinc-limited and replete cells 
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(Figure 2.7).  CPY* degradation in zinc-replete jem1 msc2 mutants was 
indistinguishable from the jem1 single mutant.  However, the jem1 msc2 mutant 
showed a marked defect in CPY* degradation in low zinc.  These studies indicate 
that zinc deficiency impairs function of components, likely Scj1p, of the ERAD 
system.  Consistent with this hypothesis, CPY* degradation was defective in a 
jem1 scj1 double mutant at both zinc levels (Figure 2.7). 
 
Zrc1p and Cot1p also contribute to ER zinc 
The ability of elevated zinc to suppress UPRE-lacZ induction in an msc2 
mutant (Figure 2.4A) indicated that other transporters in addition to Msc2p may 
also provide zinc to the ER.  Two possible candidates for this role are Zrc1p and 
Cot1p, members of the CDF protein family that transport zinc into the vacuole.  
While the steady state location of these proteins is the vacuole membrane, they 
must transit through the ER en route to that compartment.  Therefore, we tested 
the contribution of Zrc1p and Cot1p to ER function using the UPRE-lacZ reporter.  
Consistent with Zrc1p and/or Cot1p also contributing to ER zinc, induction of the 
UPRE-lacZ reporter was greatly increased in a zinc-deficient msc2 zrc1 cot1 
triple mutant relative to an msc2 mutant or wild type cells (Figure 2.8A).  To 
determine if either or both Zrc1p and Cot1p were involved, we generated a series 
of single and double mutants and assayed their effects on UPRE-lacZ induction 
in low zinc and high zinc.  In high zinc, all strains tested exhibited no UPRE-lacZ 
induction (Figure 2.8B).  Under zinc-deficient conditions, zrc1, cot1, and 
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Figure 2.7.  The msc2 mutant has defects in ER-associated degradation (ERAD) 
in low zinc.  LZM cultures of jem1 (CEY13), jem1 msc2 (CM164), and jem1 scj1 
(CEY17) expressing the CPY*-HA plasmid (pDN436U) were grown in the 
presence of cycloheximide for 0-60 minutes before protein extraction.  Lysates 
were analyzed by immunoblotting using mouse anti-HA or mouse anti-Pgk1p 
antibodies.  The intensities of the CPY*-HA bands were normalized to the Pgk1p 
bands.  Each time point was then calculated as the percentage of the zero time 
point (To) for that strain.  Shown are the averages of four experiments.  A, Plot of 
percent of To for cultures grown in low (1 µM) zinc in LZM.  B, Plot of percent of 
To for cultures grown in high (1000 µM) zinc in LZM. 
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Figure 2.8.  Zrc1p and Cot1p may also transport zinc into the ER.  A, UPRE-lacZ 
activity in wild type (WT, CM100), msc2 (CEY7), and msc2 zrc1 cot1 (CEY8) 
over a range of zinc concentrations in LZM.  Cells were grown in LZM + 10 µM 
Zn to deplete internal zinc stores prior to inoculation.  Shown are representative 
data from three experiments.  B, UPRE-lacZ activity in cells grown in low (1 µM) 
and high (1000 µM) zinc in LZM:  wild type (WT, CM100), zrc1 (CM102), cot1 
(CM103), zrc1 cot1 (CM104), msc2 (CEY7), msc2 zrc1 (averages of CEY19-21), 
msc2 cot1 (averages of CEY22, 23), msc2 zrc1 cot1 (averages of CEY8, CEY27-
29).  Shown are data from one representative experiment done in triplicate.  
Letters refer to values that are significantly different from each other, as 
determined using the Scheffe's test, with p < 0.05.  The error bars indicate ± 1 
S.D. 
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zrc1 cot1 cells showed UPR induction indistinguishable from wild type cells.  
Zinc-deficient msc2 mutant cells had increased UPRE-lacZ expression that was 
further increased in the msc2 zrc1 and msc2 cot1 mutants.  Finally, UPRE-lacZ 
induction was highest in the msc2 zrc1 cot1 mutant.  These results suggested 
that all three transporters contribute to ER function. 
 
Zinc deficiency induces the UPR in mammalian cells 
Finally, we addressed if the effects of zinc deficiency on the unfolded 
protein response was evolutionarily conserved.  In mammals, ATF6 is a member 
of the basic-leucine zipper family of transcription factors that acts analogously to 
yeast Hac1p to control the UPR (for review, see (54)).  ATF6 contains a 
transmembrane domain and is localized to the ER membrane.  Upon ER stress, 
ATF6 is proteolytically cleaved to release the N-terminal b-Zip-containing 
domain, which then translocates into the nucleus to activate UPR gene 
expression.  To address if zinc deficiency activates the UPR in mammalian cells, 
we examined the effects of zinc deficiency on expression of an ATF6-responsive 
reporter plasmid (p5xATF6GL3) (47) transiently transfected into HeLa cells.  
p5xATF6GL3 contains five copies of the ATF6 binding site inserted upstream of 
the firefly luciferase gene.  These cells were co-transfected with a lacZ gene 
driven by the SV40 promoter to normalize for differences in transfection 
efficiency.  As shown in Figure 2.9A, treating HeLa cells bearing p5xATF6GL3 
with tunicamycin, a glycosylation inhibitor and known inducer of ATF6 activity, 
resulted in a marked induction of luciferase expression.  To induce zinc  
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Figure 2.9.  Zinc deficiency induces the mammalian ER stress response.  HeLa 
cells were transiently transfected with pSV-β-galactosidase and p5xATF6GL3 
plasmids.  Cells were then subjected to different treatments, protein was 
extracted, and β-galactosidase and luciferase assays performed.  Luminometer 
readings were normalized to β-galactosidase activity values to adjust for 
differences in transfection efficiencies.  In all experiments, "un" refers to 
untransfected cells.  A, Luciferase activity in cells treated with (+Tm) and without 
(-Tm) tunicamycin (12 hours, 2 µM tunicamycin).  B, Time course of luciferase 
activity for cells treated with 5 µM TPEN for 0, 1, 2.5, 5, or 12 hours.  C, 
Concentration response of luciferase activity for cells treated with 0, 1, 2, 3, 4, or 
5 µM TPEN for 12 hours.  D, Luciferase activity in cells with different 12 hour 
treatments:  no treatment (0), 5 µM TPEN (TPEN), 5 µM TPEN and 5 µM Zn 
(TPEN+Zn), or 5 µM Zn (Zn).  The error bars indicate ± 1 S.D. 
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deficiency, cells were treated with 5 M of the zinc chelator N,N,N’N’- tetrakis-(2-
pyridylmethyl)ethylenediamine (TPEN).  Cells were then harvested over a 12 h 
period and assayed for luciferase expression.  After 5 h of TPEN treatment, a 
small increase in luciferase activity was observed (Figure 2.9B).  After 12 h, 
luciferase activity was induced ~4-fold.  No loss of cell viability was detected over 
this 12 hr period (data not shown) indicating that the induction was not due to 
necrosis or apoptosis.  To determine the concentration of TPEN optimal to 
triggering UPR induction, we assayed the effects of a range of TPEN 
concentrations following 12 h treatment.  TPEN concentrations of  3 µM had no 
effect on ATF6 activity while concentrations of 4 or 5 µM induced expression 
above basal levels (Figure 2.9C).  Finally, we addressed if the effects of TPEN 
on UPR induction were due to zinc deficiency or a pharmacological effect of 
TPEN.  Consistent with zinc deficiency being the cause, simultaneous incubation 
of cells with 5 µM TPEN and 5 µM ZnCl2 failed to induce ATF6 activity (Figure 
2.9D).  These results suggest that the requirement of the ER for zinc is 
evolutionarily conserved and that zinc deficiency induces the UPR in a wide 
range of organisms. 
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DISCUSSION 
In a previous report, Li and Kaplan proposed that Msc2p transports zinc 
out of the nucleus into the cytosol (36).  This hypothesis was based on the 
tentative localization of overexpressed Msc2p to the nuclear envelope (which is 
contiguous with the ER membrane) and the observation that the Zap1p 
transcription factor was completely repressed under their zinc-deficient 
conditions in an msc2 mutant.  We questioned this hypothesis because the 
relatively large size of the nuclear pore is unlikely to limit diffusion of Zn2+ ions 
between the cytosol and the nucleus (55).  In this report, we propose the 
alternative model that zinc is required for ER function and Msc2p transports the 
metal into the ER lumen. 
Several lines of evidence support the hypothesis that Msc2p is involved in 
zinc metabolism.  First, Msc2p is a member of the CDF family of metal ion 
transporters.  Studies of CDF proteins in many organisms have established that 
these proteins transport their metal ion substrate, usually Zn2+, from the cytosol 
to either outside of the cell or into organelles (13-16).  Thus, Msc2p is likely to be 
a zinc transporter whose topology is consistent with metal transport into the ER 
lumen.  Second, mutations in msc2 alter zinc homeostasis.  While it was shown 
previously that the Zap1p transcription factor was completely inactive in a zinc-
limited msc2 mutant (36), our experiments further clarified these earlier results by 
showing that Zap1p can still respond to zinc deficiency in an msc2 strain.  
Nonetheless, the suppression of ZRE-lacZ expression caused by the msc2 
mutation that we observed (Figure 2.3) is consistent with msc2 mutants having 
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elevated pools of labile cytosolic zinc.  Third, mutations in MSC2 result in several 
phenotypes that are zinc suppressible.  Li and Kaplan had shown that the growth 
defect of msc2 mutants on respired carbon sources at elevated temperatures is 
suppressed by zinc (36).  Here we document that zinc-deficient cells up-regulate 
their UPR system and this induction is further increased in an msc2 mutant.  Like 
the temperature-sensitive growth phenotype, induction of the UPR is zinc 
suppressible.  Finally, we present here genetic evidence that known zinc 
transporters, Zrc1p and Cot1p, play redundant roles with Msc2p.  Their 
involvement in ER function indicates that Msc2p is also a zinc transporter.  
Our results indicate that Msc2p delivers zinc to the lumen of the ER to 
maintain function of that compartment and, perhaps, other organelles of the 
secretory pathway.  While currently available methods do not allow us to assay 
lumenal ER zinc directly, several observations indirectly support this hypothesis.  
First, we found that Msc2p localizes to the ER when expressed at physiological 
levels from its own promoter.  The presence of significant amounts of Msc2p 
protein in vesicles of lighter density (+Mg2+, Figure 2.2A) suggests that some 
protein may also be found in later compartments of the secretory pathway, 
perhaps the Golgi.  Second, mutation of MSC2 activates the UPR system.  Our 
results indicate that this induction requires the full UPR signaling pathway 
consistent with actual ER stress being responsible rather than downstream 
perturbations of, for example, Hac1pi activity.  Third, we found that msc2 mutants 
show synthetic growth defects when combined with mutations in either ire1 or 
hac1.  This observation is especially intriguing in light of studies by Ng et al. in 
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which mutations were identified that were synthetically lethal when combined 
with an ire1 mutation (52).  This screen identified 16 different genes almost all of 
which were shown to be involved in ER functions such as glycosylation, GPI-
anchor synthesis, or ERAD function.  Thus, mutations in genes affecting lumenal 
ER processing events are lethal when combined with ire1 mutations.  While 
msc2 mutants were not identified in this synthetic lethal screen, they too are 
synthetically lethal with an ire1 mutation when cells are grown at 37°C.  Finally, 
we directly observed zinc-suppressible defects in one aspect of ER function, ER-
associated degradation.  We chose to examine this process because Scj1p, a 
chaperone protein of the ER lumen that is required for ERAD, is likely to be zinc 
dependent.  One caveat to this experiment is that the E3 ubiquitin-protein ligases 
required for proteasome degradation of unfolded proteins following their export 
from the ER, Hrd1p/Der3p and Doa10p/Ssm4p, may also be zinc-dependent (56, 
57).  Therefore, the defects in ERAD observed in msc2 mutants could be due to 
disruption of ligase function via alterations in cytosolic zinc homeostasis.  This 
appears not to be the case; degradation of a model cytosolic substrate of 
Doa10p, the Deg1-βgalactosidase protein (57), was unaffected by either zinc 
limitation or mutation of msc2 (data not shown).  Compromised function of 
Hrd1p/Der3p is still formally possible but less likely given the lack of effects on 
Doa10p function. 
In addition to ERAD, it is also likely that other processes occurring in the 
ER are impaired by zinc deficiency.  Several observations suggest that synthesis 
of GPI-anchors may be disrupted by these perturbations.  First, GPI-anchor 
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synthesis has been found to be zinc dependent both in vitro and in vivo (7, 8).  
Second, the yeast MCD4, LAS21, and GPI13 genes encode related proteins 
required for GPI-anchor synthesis (58-61).  These proteins all contain conserved 
domains similar to the zinc-binding sites of alkaline phosphatases (6).  While the 
precise role of these proteins is still unclear, their importance in GPI-anchor 
synthesis is well documented.  MCD4 and GPI13 are essential genes while 
LAS21 is not.  Temperature-sensitive mcd4 alleles and las21 mutants have a 
large cell morphology similar to that seen with msc2 (36, 62, 63).  Suppressors of 
these mutations also link their activity to Msc2p.  The large cell phenotype of 
las21 is suppressed by overexpression of the HSP150 gene (59).  Hsp150p is a 
cell wall protein of unknown function.  We have found HSP150 overexpression 
also suppresses the msc2 temperature-sensitive growth defect and large cell 
phenotype (data not shown).  Finally, MCD4 is a direct Zap1p target gene and is 
induced  4-fold by zinc deficiency (48).  These results suggest that GPI-anchor 
synthesis is sensitive to zinc deficiency, and MCD4 is up-regulated to maintain 
sufficient activity in zinc-limited cells.  Golgi function was unimpaired by mutation 
of the MSC2 gene; analysis of the kinetics of wild type CPY processing indicated 
no differences between wild type and mutant cells in high or low zinc (data not 
shown). 
In this study, we have identified three different transporters that likely 
contribute to ER zinc: Zrc1p, Cot1p, and Msc2p.  Of these three, Msc2p appears 
to play the predominant role because mutation of this gene alone had the 
strongest effect on UPR induction.  While Msc2p is resident in the ER 
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membrane, Zrc1p and Cot1p are most abundant in the vacuolar membrane (32, 
64).  We can suggest two possible mechanisms to explain how Zrc1p and Cot1p 
could supply zinc to the ER.  First, these proteins may mediate zinc transport 
soon after insertion into the ER membrane and prior to their transit to the 
vacuole.  Alternatively, zinc may be transferred from the vacuole lumen to the ER 
by retrograde vesicular trafficking. 
The ZRC1 gene is a Zap1p target and induced by zinc deficiency (48, 65).  
This was a surprising finding given the importance of this transporter in zinc 
storage and detoxification.  Our previous results indicated that ZRC1 up-
regulation in low zinc is required to tolerate "zinc shock" (66).  Zinc shock occurs 
when zinc-limited cells, which express high levels of the Zrt1p zinc uptake 
transporter, are resupplied with zinc.  The role of Zrc1p in supplying zinc to the 
ER is an additional reason why the ZRC1 gene may be induced in low zinc; i.e. 
to maintain ER zinc levels.  However, given the relatively minor role Zrc1p plays 
in maintaining ER function (Figure 2.8), our results argue that zinc shock 
tolerance is the major reason for the regulation of ZRC1 expression by Zap1p.   
We also predict that additional pathways contribute to ER zinc.  UPR 
induction in the msc2 zrc1 cot1 triple mutant is still suppressible by adding 10 µM 
ZnCl2 to the medium.  One possible route to bypass the loss of Msc2p, Zrc1p, 
and Cot1p activity is via fluid-phase endocytosis of zinc followed by its retrograde 
vesicular transport to the ER.  While formally possible, we do not favor this model 
based on our results.  Specifically, while UPR induction in the msc2 zrc1 cot1 
mutant is suppressed by 10 µM zinc, it requires 100-fold more zinc to suppress 
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UPRE-lacZ activity in a zrt1 mutant (Figure 2.1A).  Zrt1p transports zinc across 
the plasma membrane into the cytoplasm.  Therefore, the much higher levels of 
zinc required to suppress UPRE-lacZ expression in a zrt1 mutant strongly argues 
that that zinc must pass through the cytosol before entering the ER.  
Msc2p is related to the Zhf1 protein of S. pombe (67, 68).  Like Msc2p, 
Zhf1 is a member of the CDF family of metal ion transporters.  Furthermore, 
immunoelectron microscopy localized Zhf1 protein to the ER membrane.  
However, the phenotypic effects of zhf1 mutations argue that this protein plays a 
very different role in zinc metabolism.  While Msc2p is important for supplying 
zinc to the ER for organelle function, Zhf1 appears to be required for zinc storage 
and detoxification.  For example, zhf1 mutations increase the sensitivity of cells 
to exogenous zinc indicating its role in detoxification.  zhf1 mutants also have 
decreased zinc accumulation in cells indicating its role in zinc storage.  For 
Msc2p, we found no effect of msc2 mutations on zinc tolerance either in wild type 
or zrc1 cot1 mutant cells that are greatly sensitized to exogenous zinc (data not 
shown).  Li and Kaplan showed that msc2 mutants actually hyperaccumulate zinc 
(36).  Thus, the effects of zhf1 mutations in S. pombe are much more similar to 
mutations altering Zrc1p and Cot1p of S. cerevisiae.  The ER of S. pombe may 
play a role in zinc storage and detoxification similar to that of the vacuole in S. 
cerevisiae. 
Another protein related to Msc2p is mammalian ZnT5.  While most 
members of the CDF family have only 6 transmembrane domains, Msc2p and 
ZnT5 are predicted to have ~15 transmembrane domains.  For each, the 
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conserved CDF region is found at the C-terminus with several transmembrane 
domains attached to their N-termini.  ZnT5 was localized to the Golgi when 
expressed from the CMV promoter in HeLa cells and is widely expressed in 
mammalian tissues (21).  Expression was especially high in the β cells of the 
pancreas in which zinc is transported into secretory vesicles for the packaging of 
insulin.  Finally, ZnT5-dependent zinc transport activity could be observed in 
Golgi-derived vesicles in vitro.  Given our results indicating that zinc transport 
into the secretory pathway is important for ER stress and UPR induction, we 
predict that ZnT5 or related proteins carry out this important role in mammalian 
cells.  Consistent with this hypothesis, we have found that expression of ZnT5 in 
msc2 mutant yeast can suppress phenotypic defects of this mutant under certain 
conditions (Ellis, et al., unpublished results).
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ABSTRACT 
In this report, we demonstrate a novel interaction between two members 
of the cation diffusion facilitator (CDF) family in Saccharomyces cerevisiae.  One 
CDF member in yeast, Msc2p, was shown recently to be involved in zinc 
transport into the endoplasmic reticulum (ER) and required for ER function.  We 
present evidence here of a newly recognized CDF family member in yeast, 
Zrg17p.  ZRG17 was previously identified as a zinc-regulated gene controlled by 
the zinc-responsive Zap1p transcription factor.  A zrg17 mutant exhibits the same 
zinc-suppressible phenotypes as an msc2 mutant, including an induction of the 
unfolded protein response (UPR) in low zinc.  Zrg17p localizes to the ER and is 
regulated by zinc at the protein level.  Msc2p and Zrg17p physically interact, as 
determined by co-immunoprecipitation.  Therefore, we propose that Msc2p and 
Zrg17p form a zinc transport complex in the ER membrane to maintain the 
function of this compartment.  We also demonstrate that ZnT5 and ZnT6, the 
closest mammalian homologues of Msc2p and Zrg17p, may functionally interact.  
These results indicate that interactions between CDF members may be a 
common phenomenon. 
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INTRODUCTION 
 Zinc is required by all organisms because of the essential roles zinc plays 
in cells.  In particular, zinc is important for the activity of many proteins that reside 
in or move through the secretory pathway.  In pancreatic beta cells, zinc is 
needed for the association of proinsulin into homohexamers, which takes place in 
the endoplasmic reticulum (ER) and/or Golgi (1, 2).  The subsequent maturation 
of secreted insulin granules also requires zinc (1).  Killer T cells present antigen 
peptides on their cell surface bound to major histocompatibility complex (MHC) 
class I molecules.  The processing of some of these peptides takes place in the 
ER by the ER-associated aminopeptidase (ERAAP), which utilizes zinc in its 
active site (3, 4).  Zinc metalloenzymes responsible for attaching 
phosphoethanolamine groups to glycosylphosphatidylinositol- (GPI-) anchors are 
resident ER proteins (5, 6).  The Scj1p protein chaperone in the ER of yeast is a 
DnaJ homologue needed for ER-associated degradation (ERAD) (7, 8).  Scj1p 
requires zinc for its function (9, 10).  Lastly, protein folding in the ER and overall 
proper ER function were recently found to require zinc (10). 
 Because of these and other needs for zinc, eukaryotic cells must utilize 
zinc transport proteins in their plasma membranes and intracellular organelles.  
To maintain zinc levels in times of zinc deficiency and to have an efficient means 
of transport, cells must also regulate the transporters responsible for the uptake 
and cellular distribution of zinc.  The budding yeast Saccharomyces cerevisiae 
has been an excellent model system for studying zinc transport and regulation.  
Initial uptake of zinc into the cytoplasm of yeast is accomplished through three 
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transporters on the plasma membrane:  Zrt1p, Zrt2p, and Fet4p (11-13).  In times 
of zinc deficiency, zinc stores in the vacuole are mobilized by the Zrt3p protein to 
supply zinc to the cytoplasm and other organelles (14).  Alternatively, when zinc 
levels in the cytoplasm become replete or toxic, the Zrc1p protein is involved in 
transporting zinc into the vacuole to be stored (15). 
 The genes for all of the above yeast proteins are regulated by the zinc-
responsive transcription factor, Zap1p.  Zap1p up-regulates genes in zinc-
deficient conditions by binding to an eleven base pair consensus sequence, a 
zinc-responsive element (ZRE), found in one or more copies in the promoters of 
its target genes (16).  Lyons et al. performed microarray analysis on the yeast 
transcriptome and determined that at least 46 genes are regulated by Zap1p 
(17).  This Zap1p regulon includes genes whose protein products are involved in 
zinc homeostasis (including zinc transporters and Zap1p itself), ethanol 
metabolism (such as alcohol dehydrogenase), DNA metabolism (with the 
biosynthesis of DNA bases), and many of unknown function (17). 
 While most of the yeast zinc transporters known to date have been shown 
to be Zap1p targets, the Msc2p protein is not.  Msc2p is a member of the cation 
diffusion facilitator (CDF) family of heavy metal ion transporters (18, 19).  Many 
eukaryotic members of the CDF family have been shown to transport heavy 
metals, in particular zinc, out of the cytoplasm into intracellular organelles (18, 
20).  Msc2p has recently been shown to be localized to the ER and is involved 
with zinc uptake into this compartment (10, 21).  An msc2 mutant exhibits an up-
regulation of the unfolded protein response (UPR) and has defects in ERAD, 
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suggesting that Msc2p and zinc are needed for proper ER function (10).  The 
UPR and ERAD defects as well as other phenotypes of the msc2 mutant are all 
suppressible by zinc.  This suggested there were other zinc transporters in the 
ER/secretory pathway.  Zrc1p, and its vacuolar homologue Cot1p, were found to 
potentially contribute to ER zinc levels, for an msc2 zrc1 cot1 triple mutant 
caused a further up-regulation of the UPR in low zinc than that seen in an msc2 
mutant alone.  However, even this triple mutant was suppressed by elevated zinc 
(10).  These observations led us to look for more potential zinc transporters in the 
secretory pathway.  One such candidate was Zrg17p. 
 Previous studies on ZRG17 determined it to be a Zap1p target and 
regulated by zinc at the mRNA level, i.e., ZRG17 is up-regulated in low zinc and 
down-regulated in high zinc (17, 22).  A zrg17 mutant has an abnormal large cell 
morphology, which is suppressed by the addition of higher amounts of zinc in the 
medium (22).  An msc2 mutant also exhibits this zinc-suppressible large cell 
phenotype (21).  The Zrg17p protein is predicted to be an integral membrane 
protein with six or seven transmembrane domains (22).  A C-terminal green 
fluorescent protein (GFP) fusion construct of Zrg17p showed an ER localization, 
though this localization is tentative since the functionality of the fusion protein 
was not determined (23).  Lastly, a yeast two-hybrid screen looking for potential 
interactions between proteins across the entire yeast proteome determined a 
possible interaction between Msc2p and Zrg17p (24). 
 These data suggest that Msc2p and Zrg17p interact to form a complex 
that transports zinc into the ER.  In support of this hypothesis, we observed that 
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msc2 and zrg17 mutants both exhibit the same, but non-additive, phenotypes.  
We localized Zrg17p to the ER using a functional hemagglutinin- (HA-) tagged 
fusion construct.  We demonstrated via co-immunoprecipitation that Msc2p and 
Zrg17p physically interact.  Lastly, we determined that Zrg17p is a distant 
member of the CDF family and suggest that other CDF family members may 
interact to form hetero-complexes for heavy metal transport.
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EXPERIMENTAL PROCEDURES 
Yeast strains and media 
Media used were YPD, SD, YPGE, and LZM as described previously (25).  
Yeast strains DY150 (MATa ade2 can1 his3 leu2 trp1 ura3) and DY150 msc2 
(DY150 msc2::HIS3) (21), BY4741 (MATa his3 leu2 met15 ura3) (Research 
Genetics), ZRG17-TAP (BY4741 ZRG17::TAP) and MSC2-TAP (BY4741 
MSC2::TAP) (Open Biosystems) have been described previously.  To generate 
mutant strains CEY9 (DY150 zrg17::KanMX) and CEY11 (DY150 msc2::HIS3 
zrg17::KanMX), the KanMX cassette with 500 bp flanking the ZRG17 ORF was 
amplified by PCR from the zrg17 yeast deletion mutant (Research Genetics).  
The PCR fragment was then transformed into DY150 or DY150 msc2 to generate 
CEY9 and CEY11, respectively. 
 
Plasmids 
Plasmids used are described in Table 3.1.  pZnT5 was a gift from Taiho 
Kambe (Kyoto University, Kyoto, Japan) (26), and pZnT6 was a gift from Liping 
Huang (University of California, Davis, CA) (27).  pRS316GAL1LEU2, pYES2L, 
and pZnT5L were generated by swapping the URA3 gene on pRS316GAL1, 
pYES2, and pZnT5, respectively, for the LEU2 gene using the marker swap 
plasmid pUL9 (28).  pZRG17 and pZRG17HA were constructed the same way as 
pMSC2 and pMSC2HA (10).  Briefly, PCR products containing the ZRG17 
promoter and ORF (and terminator in the case of pZRG17) were put into pFL38 
or YCpZRC1-HA by homologous recombination to generate pZRG17 and 
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Table 3.1.  Plasmids used in this study 
________________________________________________________________ 
 
Plasmid   Relevant Genotype       Reference/ 
      Source 
________________________________________________________________ 
 
pTF63   High copy expression vector           (29) 
YEpMSC2-myc  MSC2-myc in pTF63            (21) 
pRS316GAL1  Low copy expression vector           (30) 
pRS316GAL1LEU2  Low copy expression vector      This Work 
pGAL-ZRG17HA  ZRG17-3xHA driven by GAL1 promoter     This Work 
YEp24   High copy expression vector           (31) 
pHSP150   HSP150 in YEp24             This Work 
pMCZ-Y (UPRE-lacZ) High copy expression of UPRE-lacZ          (32) 
pDg2L (ZRE-lacZ)  High copy expression of ZRE-lacZ          (14) 
pRK315   PMA1-HA driven by GAL1 promoter          (33) 
pGEV-TRP1   GAL4.ER.VP16 expression system          (34) 
pZRG17   ZRG17 in low copy vector            This Work 
pZRG17HA   ZRG17-3xHA in low copy vector      This Work 
pMSC2   MSC2 in low copy vector            (10) 
pMSC2HA   MSC2-3xHA in low copy vector           (10) 
pYES2   High copy expression vector      Invitrogen 
pYES2L   High copy expression vector      This Work 
pYES2-ZnT5 (pZnT5) ZnT5 driven by GAL1 promoter           (26) 
pZnT5L   ZnT5 driven by GAL1 promoter      This Work 
pYES2-ZnT6 (pZnT6) ZnT6 driven by GAL1 promoter           (27) 
________________________________________________________________ 
 
Unless otherwise noted, genes are driven by their own promoters. 
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pZRG17HA, respectively (35).  To generate the pGAL-ZRG17HA construct, the 
ZRG17 ORF starting at the fourth in-frame ATG plus 3xHA tags and termination 
sequence from pZRG17HA was amplified by PCR.  This fragment was then 
inserted into the Sac1 site of the vector pRS316GAL1LEU2 by homologous 
recombination.  (We determined the annotation in the Saccharomyces Genome 
Database (SGD) to be incorrect for the ATG translation start site of the ZRG17 
gene.)  All of the above plasmids encoding ZRG17 constructs were confirmed to 
be functional by complementation of the zrg17 mutant growth phenotype on 
YPGE plates at 37oC.  pGEV-TRP1 was co-transformed with pRK315 and pGAL-
ZRG17HA so that expression levels of Pma1p-HA and Zrg17p-HA could be 
controlled by the addition of β-estradiol (Sigma) (10-7 M or 10-6 M, respectively) 
(34). 
 
Isolation of pHSP150 
In a screen to identify suppressors of the msc2 mutant 37oC growth defect 
on YPGE medium, the msc2 mutant was transformed with a yeast genomic 
library in the overexpression vector YEp24.  After initial selection for the 
plasmids, transformed cells were harvested with water and subsequently plated 
onto YPGE plates at a concentration of ~ 10,000 cells per plate.  YPGE plates 
were grown at 37oC for three or four days and screened for colonies.  Plasmids 
were harvested from these colonies and sequenced.  One of the plasmids 
isolated was pHSP150, whose insert consists of a genomic fragment from yeast 
chromosome X and contains the entire HSP150 gene. 
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Growth assays 
The desired strains were grown overnight in YPD or SD with the 
appropriate auxotrophies and 10-6 M β-estradiol where indicated.  These cultures 
were subsequently diluted into the same medium, and 5 µL of diluted culture, 
yielding 104 or 103 cells, were spotted onto YPGE plates.  Where indicated, 
different concentrations of ZnCl2 and/or 10-6 M β-estradiol were added to the 
plates.  The plates were grown 3 to 4 days and photographed. 
 
β-galactosidase assays and subcellular fractionation 
β-galactosidase assays, with specific activity normalized to protein 
content, and subcellular fractionation, where protein extracts were fractionated 
on sucrose gradients +/- Mg2+, were performed as described previously (10). 
 
Zrg17p dendrogram 
 Related sequences were identified using a PSI-BLAST-generated 
Position-Specific Scoring Matrix and the resulting dendrogram is a neighbor-
joined tree generated using ClustalW (36). 
 
Protein lysates, co-immunoprecipitation, and immunoblotting 
Protein lysates for immunoblotting were obtained as follows.  Yeast 
cultures were grown to an OD600 = ~ 1.0 in LZM medium containing 1 µM or 1000 
µM Zn.  The cells were harvested, washed once with water, and resuspended in 
MIB (0.6 M mannitol, 20 mM HEPES-KOH, pH 7.4).  Protein lysates were 
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obtained using glass beads in the presence of protease inhibitors (1 mM PMSF, 
50 µg/mL leupeptin, 10 µg/mL pepstatin A, 1 mM EDTA (all from Sigma), mini 
EDTA-free protease inhibitor cocktail pellets (Roche)) and vortexing 10 x 30 
seconds, with 30 seconds on ice in-between pulses.  The cell debris was pelleted 
by centrifuging 2 minutes at 500 x g at 4oC.  The resulting supernatant was the 
total protein lysate.  To separate membrane-bound proteins from cytosol, total 
protein lysates were centrifuged 30 minutes at ~ 100,000 x g at 4oC in a TLS55 
swinging bucket rotor in a Beckman Optima TL tabletop ultracentrifuge.  The 
membrane pellet was resuspended in MIB plus protease inhibitors.  Ten µg 
protein was loaded per lane for SDS-PAGE and immunoblotting. 
Protein lysates for co-immunoprecipitation were obtained as described 
above, with the exception that they were generated in 50 mM NaCl instead of 
MIB.  The lysates were then solubilized with 3% LM (n-dodecyl-β-D-maltoside) 
(MP Biomedicals) on ice for 2 hours.  The insoluble proteins were pelleted by 
centrifuging 15 minutes at 15,000 x g at 4oC.  The detergent-soluble protein 
lysates were diluted 1:3 into IPP150 buffer (10 mM Tris-Cl, pH 8.0, 150 mM 
NaCl), then 50 µL IgG-Sepharose beads (Amersham Pharmacia) were added to 
each lysate.  The lysates + beads were rotated at 4oC for 30 minutes, after which 
the beads were washed 4 times with IPP150 buffer + 0.1% LM.  The beads were 
resuspended in elution buffer (50 mM Tris-Cl, pH 8.0, 10 mM EDTA, 1% SDS) 
and incubated at 65oC for 30 minutes to elute the proteins off the beads.  Equal 
volumes of eluted protein lysates were loaded onto SDS-PAGE for 
immunoblotting. 
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When denatured by boiling, epitope-tagged Zrg17p exhibited high 
molecular weight aggregates on immunoblots (data not shown).  Therefore, 
lysates containing epitope-tagged Zrg17p were always denatured for 30 minutes 
at either 37oC or 65oC prior to SDS-PAGE.  Immunoblots were done by standard 
techniques (37).  Blots were visualized with POD (Roche).  Band quantitation to 
determine fold difference in protein levels was performed using NIH Image 1.61.  
Antibodies used were rabbit anti-HA (Sigma), mouse anti-HA (12CA5, Roche), 
mouse anti-Dpm1p (Molecular Probes), rabbit anti-Kex2p (gift of Steven 
Nothwehr, University of Missouri, Columbia, MO), goat anti-mouse HRP-
conjugated secondary (Pierce), and goat anti-rabbit HRP-conjugated secondary 
(Pierce). 
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RESULTS 
msc2 and zrg17 mutants exhibit the same phenotypes 
 An msc2 mutant was shown previously to exhibit several zinc-
suppressible phenotypes, including an abnormal large cell morphology (21).  
Since a zrg17 mutant also exhibited this same zinc-suppressible large cell 
phenotype (22), we wondered if a zrg17 mutant would exhibit other phenotypes 
seen in an msc2 mutant.  Therefore, we generated an isogenic strain where the 
ZRG17 gene was deleted from the genome (see Experimental Procedures).  We 
also generated an msc2 zrg17 double deletion strain to determine if the single 
mutant phenotypes were additive when combined. 
An msc2 mutant was shown to have a growth defect at 37oC when grown 
on rich medium plates containing glycerol and ethanol, YPGE (21).  As seen in 
Figure 3.1A, both the zrg17 and msc2 zrg17 mutants also exhibited this same 
temperature-sensitive growth defect.  When ≥ 500 µM zinc was added to the 
plates, the growth of all three mutants was recovered.  To determine if the single 
mutants were recovered by different amounts of zinc, a range of zinc 
concentrations was added to the plates.  Both msc2 and zrg17 single mutants 
showed slight growth with the addition of 100 µM zinc and were recovered 
similarly by the addition of 250 µM Zn, though the msc2 mutant grew slightly 
better than the zrg17 mutant at this concentration.  The double mutant showed 
similar growth to the single mutants at all zinc concentrations, demonstrating that 
this phenotype is not additive. 
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Figure 3.1.  The msc2 and zrg17 mutants exhibit a zinc-suppressible 37oC 
growth defect.  Yeast cells were grown in liquid medium overnight.  Cultures 
were diluted into fresh medium and 5 µL volumes were plated onto YPGE plates, 
incubated at 30oC or 37oC, and photographed after 3 or 4 days.  A, Wild type 
(WT, DY150), msc2 (DY150 msc2), zrg17 (CEY9), and msc2 zrg17 (CEY11) 
cells were grown overnight in YPD, and 104 cells were plated onto YPGE plates 
containing the indicated amounts of ZnCl2.  B, Wild type (WT, DY150), msc2 
(DY150 msc2), zrg17 (CEY9), and msc2 zrg17 (CEY11) cells expressing YEp24 
(vector) or pHSP150 were grown overnight in SD, and 104 cells were plated onto 
YPGE plates.  C, Wild type (WT, DY150), msc2 (DY150 msc2), and zrg17 
(CEY9) cells were grown overnight in SD + 10-6 M β-estradiol.  103 cells were 
plated onto YPGE plates containing 10-6 M β-estradiol and the indicated amounts 
of ZnCl2.  All strains expressed pGEV-TRP1, as well as the following plasmid 
combinations:  pTF63 + pRS316GAL1LEU2 (vectors), YEpMSC2-myc + 
pRS316GAL1LEU2 (YEpMSC2-myc), or pTF63 + pGAL-ZRG17HA (pGAL-
ZRG17HA). 
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 We performed an overexpressor screen looking for genes that could 
suppress the msc2 mutant 37oC growth defect and isolated a genomic fragment 
that contained the HSP150 gene (see Experimental Procedures).  Hsp150p is a 
cell wall protein whose exact function is unknown.  As seen in Figure 3.1B, the 
genomic fragment containing HSP150 (pHSP150) suppressed the growth defect 
of the zrg17 mutant as well as the msc2 zrg17 double mutant.  This suggests that 
Msc2p and Zrg17p are involved with the same function or pathway in the cell, 
since the same gene can suppress both the msc2 and zrg17 mutants. 
If Msc2p and Zrg17p separately perform the same function in the cell 
(e.g., ER zinc transport), then overexpression of one gene might be able to 
compensate for the loss of the other.  Therefore, we generated a C-terminal 
3xHA-tagged construct of ZRG17 driven by the GAL1 promoter, which can 
generate high expression of ZRG17 through use of the β-estradiol inducible 
pGEV system (see Experimental Procedures).  We also overexpressed MSC2 
using a C-terminal myc-tagged construct on a high copy plasmid (21).  C-terminal 
HA-tagged constructs of MSC2 and ZRG17 on low copy plasmids (pMSC2HA 
and pZRG17HA) complement the 37oC growth defect of the msc2 and zrg17 
mutants, respectively (data not shown).  This indicates that C-terminal tags do 
not interfere with the activity of the Msc2p and Zrg17p proteins at normal levels. 
To determine if overexpression of one gene compensates for the loss of 
the other, we introduced the MSC2 and ZRG17 overexpression systems into the 
msc2 and zrg17 single mutants and grew them on YPGE plates at 37oC.  Figure 
3.1C shows that, without added zinc in the plates, the msc2 mutant was only 
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recovered by the overexpression of MSC2, and the zrg17 mutant was only 
recovered by the overexpression of ZRG17.  Even with additional zinc added to 
the plates, overexpression of ZRG17 did not encourage growth of the msc2 
mutant above expression of vectors alone, and vice versa for the zrg17 mutant.  
Therefore, overexpression of Msc2p and Zrg17p cannot compensate for loss of 
the other protein.  This result suggests one of two things.  Either Msc2p and 
Zrg17p perform separate steps in the same pathway, or they interact together so 
that both are needed to perform the same function in the same compartment. 
Another phenotype of the msc2 mutant is the up-regulation of the unfolded 
protein response (UPR) in zinc-limiting conditions (10).  The UPR is a response 
by cells whereby they up-regulate protein chaperones and degradation systems 
to refold and/or degrade misfolded proteins in the ER.  We introduced a UPR 
reporter construct (UPRE-lacZ) into the zrg17 and msc2 zrg17 mutants and 
determined the activity of this reporter over a range of zinc concentrations.  Like 
the msc2 mutant, the zrg17 and double mutants also exhibited elevated UPRE-
lacZ activity in low zinc (LZM + 0.3-10 µM ZnCl2) compared to wild type cells 
(Figure 3.2).  The double mutant showed a similar amount of activity as both 
single mutants, demonstrating that this phenotype is also not additive.  (The 
different expression levels at LZM + 1 µM ZnCl2 between the msc2 mutant and 
the zrg17 and msc2 zrg17 mutants is not reproducible in other experiments; the 
three mutants show similar levels of UPRE-lacZ activity at LZM + 1 µM ZnCl2.)  
We have shown previously that activity of a HIS4-lacZ reporter, which is not 
responsive to either zinc or unfolded proteins, showed high expression in both 
104 
Figure 3.2.  The msc2 and zrg17 mutants increase UPR induction in zinc 
deficiency.  UPRE-lacZ activity in wild type (WT, DY150), msc2 (DY150 msc2), 
zrg17 (CEY9), and msc2 zrg17 (CEY11) strains over a range of zinc 
concentrations in LZM.  Shown is one representative experiment from a total of 
three independent experiments.  The error bars indicate ± 1 S.D. 
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wild type and mutant strains at all zinc concentrations (10).  This indicates that 
the results presented here are specific to the UPRE-lacZ reporter and not a 
general effect on all lacZ reporters.  Therefore, the UPRE-lacZ results suggest 
that Zrg17p is needed to maintain protein folding in the ER and perhaps ER 
function. 
Msc2p has been postulated to be involved with zinc transport, due in part 
to the result that an msc2 mutant may have elevated cytoplasmic zinc levels in 
zinc-deficient medium, as determined using a ZRE-lacZ reporter (10).  If Msc2p 
and Zrg17p are involved in the same process, then perhaps a zrg17 mutant also 
affects the cytosolic zinc pool.  Therefore, we introduced the ZRE-lacZ reporter 
into the zrg17 and msc2 zrg17 mutants to determine if these strains also have 
higher levels of cytoplasmic zinc.  In wild type cells, Zap1p is more active in low 
zinc, resulting in high activity of the ZRE-lacZ reporter (Figure 3.3).  Then, with 
increasing zinc concentrations, Zap1p becomes less active, resulting in 
decreased expression of the reporter.  The reporter expression profile in the 
msc2, zrg17, and msc2 zrg17 mutants was quite different from the wild type 
profile.  All three mutants had lower reporter activity in LZM + 1-30 µM ZnCl2 than 
that seen in wild type cells.  Once more, this phenotype was not additive in the 
double mutant.  These results suggest that Zap1p is sensing higher amounts of 
zinc in the cytoplasm of these mutants, and is consistent with Zrg17p, like 
Msc2p, being needed to sequester this zinc into an intracellular compartment. 
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Figure 3.3.  The msc2 and zrg17 mutants increase labile zinc levels.  ZRE-lacZ 
activity in wild type (WT, DY150), msc2 (DY150 msc2), zrg17 (CEY9), and msc2 
zrg17 (CEY11) strains grown over a range of zinc concentrations in LZM.  Shown 
is one representative experiment from a total of three independent experiments.  
The error bars indicate ± 1 S.D.   
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Zrg17p is localized to the endoplasmic reticulum (ER) 
 With the zrg17 mutant exhibiting the same phenotypes as an msc2 
mutant, this suggested that Zrg17p might be working in the same compartment 
as Msc2p, which was previously established to be the ER (10, 21).  Previous 
localization studies of Zrg17p using fluorescence microscopy of a C-terminal 
GFP-tagged construct of Zrg17p suggested it to be localized to the ER (23).  
However, this tagged construct was not shown to be functional, leaving this 
localization tentative.  Therefore, we set out to determine if Zrg17p was indeed 
localized to the ER. 
 We generated a construct of ZRG17 on a low copy plasmid, where ZRG17 
was driven by its own promoter and had three HA tags fused to its C-terminus 
(see Experimental Procedures).  This construct of Zrg17p was shown to be 
functional by its complementation of the zrg17 mutant 37oC growth defect (data 
not shown).  This HA-tagged Zrg17p, when detected on immunoblots, gave two 
bands when the protein was denatured at 37oC (see Figures 3.4 and 3.6A).  The 
upper band of this doublet is the appropriate size for a 3xHA-tagged Zrg17p.  
However, in recent experiments, we have observed that the lower band of this 
doublet disappeared when denatured at higher temperatures (65oC) (see Figure 
3.5B), suggesting that the doublet is due to differences in the folded state of the 
protein and not due to glycosylation or other protein modifications. 
 We determined the localization of Zrg17p using subcellular fractionation.  
Briefly, protein lysates were generated from wild type cells grown in low zinc 
(LZM + 1 µM ZnCl2) and expressing the HA-tagged Zrg17p construct.  These 
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lysates were layered onto 20%-60% sucrose gradients and centrifuged overnight 
at 4oC.  Gradient fractions were collected and proteins were visualized by 
immunoblotting, using antibodies against HA or organellar marker proteins.  The 
presence of magnesium has been shown to alter the position of ER vesicles in 
sucrose gradients (38).  In the absence of magnesium (and in the presence of 
EDTA), the ER co-fractionates with the Golgi apparatus in the middle fractions of 
the gradient.  However, in the presence of magnesium, the ER shifts to heavier 
fractions, co-fractionating with the plasma membrane.  This shift to heavier 
fractions is likely due to ribosomes remaining associated with the ER when 
magnesium is present.  If Zrg17p is localized to the ER, it should exhibit this 
diagnostic magnesium shift. 
Figure 3.4 shows the immunoblot results of fractions from gradients 
prepared with or without magnesium.  Significantly more Zrg17p was found in the 
heavier fractions of the gradient prepared with magnesium than the gradient 
without magnesium, co-fractionating with the plasma membrane marker, HA-
tagged Pma1p.  Zrg17p was found strictly in the middle fractions of the gradient 
prepared without magnesium, co-fractionating with the Golgi marker, Kex2p.  In 
both gradients, Zrg17p co-localized with the ER marker, Dpm1p, which also 
showed the magnesium shift.  Since Zrg17p shows the diagnostic magnesium 
shift for the ER and co-localizes with an ER marker, these data support the 
localization of Zrg17p to the ER.  In the gradient containing magnesium, some 
Zrg17p was also found in the middle fractions, suggesting not all Zrg17p is found 
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Figure 3.4.  Zrg17p is localized to the endoplasmic reticulum.  Lysates were 
prepared from wild type (DY150) cells expressing either pZRG17HA (grown in 
LZM + 1 M ZnCl2) or pGEV-TRP1 + pRK315 (Pma1p-HA) (grown in SD + 10-7 
M -estradiol).  Extracts were layered onto sucrose gradients for subcellular 
fractionation.  Gradient fractions were subjected to immunoblotting and probed 
with anti-HA, anti-Kex2p, or anti-Dpm1p antibodies.  Fractions are numbered 
from 1 (heaviest) to 11 (lightest).  Shown are immunoblots of +Mg and -Mg 
gradient fractions, which are representative of four independent experiments.  
Note that Zrg17p-HA appears as two bands due to the incomplete denaturation 
of the protein at 37oC. 
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in the ER.  There might be some Golgi localization of Zrg17p.  This was also the 
case for the localization of Msc2p (10). 
 
Msc2p and Zrg17p physically interact 
With Msc2p and Zrg17p both localizing to the ER, coupled with the 
previous study suggesting that these two proteins interacted (24), we wanted to 
determine if Msc2p and Zrg17p work together as a complex.  To do this, we 
performed co-immunoprecipitation of HA-tagged Msc2p and tandem affinity 
purification- (TAP-) tagged Zrg17p.  The TAP tag consists of a calmodulin 
binding protein followed by a tobacco etch virus (TEV) protease cut site and ends 
with protein A, which can bind to IgG proteins (39).  We obtained a strain where a 
TAP tag was fused to the C-terminus of ZRG17 in the genome, and we verified 
functionality of this strain by its wild type levels of UPR induction in low zinc (data 
not shown). 
 Protein lysates for co-immunoprecipitation (co-IP) were generated from 
cells grown in low zinc (LZM + 1 µM ZnCl2).  The lysates were solubilized with 
detergent then added to IgG-Sepharose beads.  The proteins were allowed to 
bind to the beads, then the beads were washed and proteins eluted.  The eluted 
proteins were analyzed by immunoblotting by probing with a rabbit anti-HA 
antibody, which can recognize both the HA and TAP tags.  If Msc2p and Zrg17p 
specifically interact with each other, Msc2p-HA should be precipitated only when 
Zrg17p-TAP is present to bind to IgG-Sepharose beads. 
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 The immunoblotting results are shown in Figure 3.5.  Wild type cells 
expressing untagged Msc2p (Figure 3.5A, lane 5) showed a non-specific band 
seen in a beads-only mock co-IP control (data not shown).  Wild type cells 
expressing HA-tagged Msc2p showed a weak Msc2p band (lane 6), indicating 
some non-specific binding of Msc2p-HA to the IgG-Sepharose beads.  ZRG17-
TAP cells expressing untagged Msc2p showed the Zrg17p band (lane 7).  Lastly, 
ZRG17-TAP cells expressing HA-tagged Msc2p showed both Msc2p and Zrg17p 
bands (lane 8).  Despite some non-specific binding of Msc2p-HA to the IgG-
Sepharose beads in the absence of Zrg17p-TAP, approximately five to ten times 
more Msc2p-HA was recovered when Zrg17p-TAP was present.  This result 
indicates that Msc2p and Zrg17p physically interact in low zinc.  This interaction 
was also observed using cells grown in high zinc (data not shown). 
To confirm the interaction between Msc2p and Zrg17p, we also performed 
the reciprocal experiment using TAP-tagged Msc2p and HA-tagged Zrg17p 
(Figure 3.5B).  Here, we obtained similar results, where five to ten times more 
Zrg17p-HA was precipitated in the presence of Msc2p-TAP.  To verify that this 
interaction between Msc2p and Zrg17p was specific and not a general interaction 
between two ER proteins, we also checked for the presence of Dpm1p in our co-
IP samples.  No detectable Dpm1p was seen in any of these samples (data not 
shown), indicating that the interaction between Msc2p and Zrg17p was specific 
and not due to incomplete solubilization of ER membranes.
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Figure 3.5.  Msc2p and Zrg17p physically interact.  Lysates were prepared from 
cells grown in LZM + 1 µM ZnCl2 for co-immunoprecipitation.  Lysates were 
solubilized with detergent, diluted with buffer, and added to IgG-Sepharose 
beads.  Bound proteins were eluted off the beads and subjected to 
immunoblotting, probing with anti-HA antibody, which recognizes both HA and 
TAP tags.  The asterisk denotes a background band observed in all co-IP 
samples regardless of the presence or absence of tagged proteins.  Shown are 
representative immunoblots from three independent experiments.  A, Co-
immunoprecipitation of wild type (BY4741) and ZRG17-TAP cells expressing 
pMSC2 or pMSC2HA.  B, Co-immunoprecipitation of wild type (BY4741) and 
MSC2-TAP cells expressing pZRG17 or pZRG17HA. 
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Msc2p and Zrg17p protein levels are regulated by zinc 
 ZRG17 is a Zap1p target and is regulated by zinc at the mRNA level (17, 
22).  MSC2, on the other hand, is not a Zap1p target nor regulated by zinc (17).  
These data suggest that Zrg17p may regulate the activity of the Msc2p-Zrg17p 
complex, such that the levels of Zrg17p in the ER membrane determine the zinc 
transport activity of the complex.  Therefore, we determined if Msc2p and/or 
Zrg17p protein levels were regulated by zinc.  We generated protein lysates of 
cells grown in low zinc (LZM + 1 µM ZnCl2) or high zinc (LZM + 1000 µM ZnCl2) 
and expressing the HA-tagged constructs of Msc2p or Zrg17p driven by their own 
promoters on low copy plasmids.  To look for an enrichment of these proteins in 
membranes, the membrane-bound fractions were separated from the cytosolic 
fractions in the lysates.  The lysates and membranes were then subjected to 
immunoblotting. 
Zrg17p had approximately three-fold higher protein levels in low zinc than 
in high zinc, both in total protein lysates and in the fractions enriched for 
membranes (Figure 3.6A).  Interestingly, Msc2p also showed three to four times 
higher protein levels in low zinc than in high zinc (Figure 3.6B).  Since this 
regulation of Msc2p protein levels cannot be due to different levels of transcript, 
this indicates a post-transcriptional regulation of Msc2p protein.  An attractive 
hypothesis would be that the interaction with Zrg17p prevents Msc2p 
degradation.  In low zinc, when more Zrg17p is present, Msc2p is not effectively 
degraded.  However, in high zinc, with lower levels of Zrg17p, less Msc2p is 
found complexed to Zrg17p, and the uncomplexed Msc2p proteins would be 
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Figure 3.6.  Msc2p and Zrg17p protein levels are regulated by zinc.  Lysates 
were prepared from wild type cells grown in low zinc (LZM + 1 µM ZnCl2) or high 
zinc (LZM + 1000 µM ZnCl2).  Membrane-bound proteins were separated from 
cytosol by high-speed ultracentrifugation.  Total protein lysates (L) and 
membrane fractions (M) from two or three independent samples were subjected 
to immmunoblotting, probing with anti-HA antibody.  Shown are representative 
immunoblots from two independent experiments.  A, Wild type (DY150) cells 
expressing pZRG17 (WT) or pZRG17HA.  Blot was probed with mouse anti-HA 
antibody, which also recognizes a non-specific cytosolic protein.  Note that 
Zrg17p-HA appears as two bands due to the incomplete denaturation of the 
protein at 37oC.  B, Wild type (DY150) cells expressing pMSC2 (WT) or 
pMSC2HA.  Blot was probed with rabbit anti-HA antibody. 
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targeted for degradation.  Therefore, despite the fact that Msc2p protein levels 
are affected by zinc concentration, Zrg17p may still perform a regulatory role in 
the complex.  More experiments are needed to determine if this is the case.  
 
Zrg17p is a distant relative of the CDF family 
 Since Msc2p and Zrg17p interact and Msc2p is a CDF protein, we 
postulated that Zrg17p might be a member of the CDF family, as well.  Most CDF 
family members have been identified by their homology to other known members 
of the family.  Zrg17p has not been previously identified in any of these searches 
as a CDF member.  Using PSI-BLAST, we found that Zrg17p was homologous to 
several proteins in other fungi and was a distant homologue to the mammalian 
ZnT6 protein (Figure 3.7).  ZnT6 is a member of the CDF family, suggesting that 
Zrg17p is also a member of this family.  The co-immunoprecipitation data then 
suggest that two different CDF members interact. 
 
Mammalian CDF homologues complement the msc2 and zrg17 mutant growth 
phenotype 
 The closest mammalian homologue to Msc2p is ZnT5 (18), and we found 
the closest mammalian homologue to Zrg17p is ZnT6.  Given the interaction 
between Msc2p and Zrg17p, we postulated that their mammalian homologues 
might also interact.  To test this, we introduced plasmids overexpressing ZnT5 
and/or ZnT6 into the msc2, zrg17, and msc2 zrg17 mutants and determined the 
ability of the mammalian genes to functionally complement the 37oC mutant 
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Figure 3.7.  Zrg17p is a distant member of the CDF family.  PSI-BLAST was 
used to identify homologues to the Zrg17p protein, and a dendrogram of selected 
homologues was created using ClustalW.  Where a common name is not given, 
the proteins are noted by Genbank accession numbers. 
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growth defect.  As seen in Figure 3.8, ZnT5 or ZnT6 alone could not suppress 
the growth phenotype of any of the three mutants.  Even when excess zinc was 
added to the plates, cells expressing just ZnT5 or ZnT6 did not grow any better 
than cells expressing vectors alone.  However, when both ZnT5 and ZnT6 were 
present, the growth defect of the mutants was markedly suppressed, with or 
without additional zinc.  These results suggest that ZnT5 and ZnT6 interact in 
yeast to form a functional complex to transport zinc into the secretory pathway.
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Figure 3.8.  Mammalian ZnT5 and ZnT6 functionally complement the 37oC 
growth defect of the msc2 and zrg17 mutants.  A, Wild type (WT, DY150), B, 
msc2 (DY150 msc2), C, zrg17 (CEY9), and D, msc2 zrg17 (CEY11) cells were 
grown in SD liquid medium + 10-6 M β-estradiol overnight.  Cultures were diluted 
in fresh medium, and 5 µL volumes (104 cells) were plated onto YPGE plates 
containing 10-6 M β-estradiol and the indicated amounts of ZnCl2.  The plates 
were incubated at 30oC or 37oC, and photographed after 4 days.  All strains 
expressed pGEV-TRP1, as well as the following plasmid combinations:  pYES2 + 
pYES2L (vectors), pYES2 + pZnT5L (pZnT5), pYES2L + pZnT6 (pZnT6), 
pZnT5L + pZnT6 (pZnT5 and pZnT6). 
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A novel interaction 
 Previous work on Zrg17p suggested it might have a role in zinc 
homeostasis in yeast.  The potential ER localization of Zrg17p (1), coupled with 
the zinc suppressible large cell phenotype of the zrg17 mutant (2), and the 
potential interaction with Msc2p (3) compelled us to further study and 
characterize this protein.  We present evidence here that Zrg17p is a member of 
the cation diffusion facilitator (CDF) family and interacts with Msc2p to make a 
functional complex in the membrane of the ER to transport zinc into this 
compartment.  Several CDF members have been postulated or shown to form 
homodimers or other higher order homo-oligomeric species (4-7).  However, no 
CDF family members to date have been shown to interact with another CDF 
family member.  This is the first definitive evidence of a physical interaction 
between two different CDF proteins. 
 
Zrg17p is involved with zinc transport into the ER 
 Several lines of evidence suggest that Zrg17p is involved with zinc 
transport in yeast.  First, ZRG17 is a Zap1p target and is regulated by zinc at the 
mRNA (2, 8) and protein levels (Figure 3.6).  Second, all of the zrg17 mutant 
phenotypes are suppressible by zinc.  These include the large cell phenotype (2), 
the 37oC growth defect (Figure 3.1), and the up-regulation of the unfolded 
protein response (UPR) (Figure 3.2).  Third, a zrg17 mutant may have increased 
cytosolic zinc levels in zinc-deficient medium, as determined by ZRE-lacZ activity 
(Figure 3.3), suggesting Zrg17p is needed to put that zinc into an intracellular 
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compartment.  Fourth, Zrg17p is a transmembrane domain protein and a distant 
member of the CDF family (Figure 3.7), whose eukaryotic members have often 
been shown to transport heavy metals, particularly zinc, out of the cytoplasm and 
into intracellular organelles (9-11).  Zrg17p has been localized to the ER and 
possibly the Golgi ((1), Figure 3.4); therefore, Zrg17p could potentially be 
transporting zinc into these compartments.  Lastly, the zrg17 mutant growth 
defect at 37oC is suppressed by the expression of both ZnT5 and ZnT6 (Figure 
3.8).  ZnT5-dependent transport activity was observed in Golgi-enriched vesicles 
from HeLa cells (12).  Therefore, the ZnT5-ZnT6 complex could be compensating 
for the lack of zinc transport activity in a zrg17 mutant.  All of the above evidence 
suggests that Zrg17p is an ER zinc transporter or aids in the transport of zinc into 
the ER. 
 
Msc2p and Zrg17p form a zinc transport complex 
Given the evidence that the msc2 and zrg17 mutants exhibit the same 
zinc-suppressible phenotypes (Figures 3.1 and 3.2), and that Zrg17p may be a 
zinc transporter, this suggests that Msc2p and Zrg17p are involved in the same 
pathway (i.e., zinc transport) in the cell.  Therefore, several models were initially 
proposed to define the relationship between Msc2p and Zrg17p.  (1) Msc2p and 
Zrg17p work as independent transporters.  However, this model is negated by 
the evidence that overexpression of one protein cannot compensate for the loss 
of the other (Figure 3.1), and the msc2 and zrg17 mutant phenotypes are not 
additive in the double mutant (Figures 3.1-3.3).  (2) Msc2p and Zrg17p work 
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together as a complex in the same compartment.  This model is supported by the 
co-immunoprecipitation data that suggest Msc2p and Zrg1p interact (Figure 3.5), 
and by the localization patterns of Msc2p and Zrg17p showing they are both in 
the ER and possibly the Golgi ((13), Figure 3.4).  (3) Msc2p and Zrg17p interact, 
but one may function only as a regulator for the other.  The possibilities of Zrg17p 
serving as the regulator of the complex are discussed in a later section.  (4) One 
protein transports a substrate that is needed for the transport activity of the other 
protein.  For example, Zrg17p may transport protons into the ER so that Msc2p 
could use an antiport mechanism to exchange protons for zinc.  Experiments to 
determine the transport ability of the complex (discussed in the next section) 
could address this model.  Even if one of these last two models is correct, they 
could still support the model that Msc2p and Zrg17p interact to form a complex. 
Another possibility that could explain the evidence presented in chapter 
three is that the absence of one protein affects the subcellular localization of the 
other.  In other words, Msc2p may require interaction with Zrg17p to be localized 
to the ER, and the zrg17 mutant phenotypes could be explained by the mis-
localization of Msc2p.  Alternatively, this could be true for Zrg17p in an msc2 
mutant.  We have determined by subcellular fractionation and 
immunofluorescence microscopy that under zinc-replete conditions, Msc2p is 
localized to the ER in a zrg17 mutant (data not shown).  However, we still need 
to verify that this occurs in low zinc conditions, as well as determine if Zrg17p is 
localized normally in an msc2 mutant.  
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Further studies on the Msc2p-Zrg17p complex 
We can infer zinc transport ability of an Msc2p-Zrg17p complex based on 
ZRE-lacZ activity assays and suppression of the mutant growth phenotypes by 
ZnT5 and ZnT6.  However, the best means of showing transport function of the 
complex would be a direct assay.  This assay would need to be specific to zinc, 
as well as sensitive enough to detect minute changes in zinc status.  
Demonstrating an increase in zinc uptake into liposomes containing purified 
Msc2p and Zrg17p is perhaps the best method.  However, alternative methods 
would determine the zinc transport activity of isolated ER microsomes.  One such 
method would use radioactive zinc and demonstrate an increased uptake of this 
zinc into microsomes only when both Msc2p and Zrg17p are present.  A second 
method would use a zinc-binding dye or fluorophore, such as zinquin or FuraZin-
1, which is more sensitive and safer than using radioactive zinc.  This dye would 
be loaded into microsomes before the addition of zinc, and then the fluorescence 
given off by the zinc-bound dye would be monitored over time.  The rate and 
maximum amount of fluorescence should depend on the presence of Msc2p and 
Zrg17p in the microsomal membranes. 
Several aspects of the nature of the Msc2p-Zrg17p complex are still to be 
determined.  First and foremost is determining the domains of interaction in both 
Msc2p and Zrg17p.  The interaction is most likely between hydrophobic 
transmembrane domains (TMs) in the lipid bilayer; however, there may be other 
parts of the proteins which associate.  Strategic mutagenesis of suspected 
regions of interaction or random mutagenesis of the genes encoding both 
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proteins could be employed to determine the regions and/or amino acids 
necessary for interaction.  The Msc2p protein has approximately 15 TMs, but the 
last six are the most homologous to other members of the CDF family.  It is 
entirely possible that the extra nine or so N-terminal TMs of Msc2p are not 
needed for transport activity but rather for interaction with Zrg17p.  Also, we 
cannot assume that the stoichiometry of the complex is 1:1.  Msc2p may also 
interact with itself, forming more than a 1:1 complex with Zrg17p.  An easy way to 
test if Msc2p interacted with itself would be co-immunoprecipitation with two 
different tagged versions of Msc2p.  This method could also be used to 
determine if Zrg17p homo-oligomerized.  Alternatively, native PAGE could be 
employed to determine the sizes of Msc2p-Zrg17p oligomers and the possible 
stoichiometries of the complex. 
If the Msc2p-Zrg17p complex is 1:1, this would still amount to about 22 
TMs in the complex.  If all 22 TMs are needed for transport, it may be that the 
complex does not transport ionic zinc, but rather a larger molecule such as a 
zinc-chelate, or a zinc-bound protein.  Alternatively, not all 22 TMs may be 
needed for the transport of zinc into the ER.  As discussed below, Zrg17p may 
merely play a regulatory role to govern the activity of Msc2p and not be needed 
for the actual transport of zinc.  Accordingly, the first nine TMs of Msc2p may not 
be necessary for transport, either, indicating that the last six TMs of Msc2p 
encompass the actual transport pore in the membrane.  To test this, we could 
generate a truncated form of Msc2p containing only the last six TMs.  If this C-
terminal part of the protein is independently functional for zinc transport, we 
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should be able to see zinc uptake activity of this construct using one of the 
methods previously described.  This assay could be performed in the presence 
or absence of Zrg17p to determine the effect of Zrg17p on this truncated Msc2p.  
The truncated protein could also be tested for functionality by its ability to 
suppress the msc2 mutant phenotypes, such as the 37oC growth defect and the 
UPR induction in low zinc. 
Lastly, many CDF members transport more than one type of heavy metal 
(14-17).  While the characterization of Msc2p and Zrg17p thus far has been in 
the context of zinc transport, the complex may have a wider substrate specificity.  
Assays used to determine the zinc transport ability of the complex can also be 
used to determine which other metals may be transported by the complex. 
 
Zrg17p may regulate the activity of the complex 
We determined that Zrg17p protein levels are regulated by zinc (Figure 
3.6), which fits nicely with the zinc regulation of ZRG17 mRNA.  This data 
supports the model that Zrg17p may regulate the activity of the Msc2p-Zrg17p 
complex.  The predication of this would be that more Zrg17p protein is expressed 
in low zinc so that more complex is formed in the ER membrane, leading to 
higher zinc transport ability to maintain constant zinc transport in low zinc.  To 
test this regulatory role of Zrg17p, an indirect assay would be to determine the 
effects of ZRG17 overexpression on ZRE-lacZ activity.  Presumably only 
overexpression of ZRG17 and not MSC2 would cause a decrease in cytosolic 
zinc, resulting in more Zap1p activity and higher ZRE-lacZ activity in wild type 
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cells.  A more direct assay would be to examine the amount of fluorescence 
given off by the zinc-dependent dye in microsomes when different amounts of 
Zrg17p are expressed, but with a constant level of Msc2p. 
Interestingly, while MSC2 shows no zinc regulation at the mRNA level, 
Msc2p protein is regulated by zinc.  Despite lower levels of Msc2p protein in high 
zinc, there is still plenty of Msc2p protein present for complex formation, for 
similar amounts of Msc2p were precipitated in the co-immunoprecipitation 
experiments in both low and high zinc (data not shown).  Two possible reasons 
for the zinc-dependent protein levels of Msc2p are (1) high zinc slows the 
translation of Msc2p or (2) Msc2p is being degraded in high zinc.  To test if 
Msc2p translation is affected by zinc concentration, cells could be grown in high 
or low zinc in the presence of cycloheximide for a period of time to inhibit 
translation.  Then, the cells can be transferred to fresh medium lacking 
cycloheximide and allowed to re-initiate translation for different lengths of time, 
after which cells can be harvested to generate protein lysates.  If Msc2p 
translation is slower in high zinc, we should see a difference in the amount of 
new Msc2p being made in high zinc versus low zinc after the cells are released 
from cycloheximide inhibition. 
For the possibility that the Msc2p protein is being degraded in high zinc, 
we can propose two models:  Zrg17p-dependent and Zrg17p-independent.  The 
Zrg17p-dependent model predicts that when Msc2p is complexed to Zrg17p, it is 
protected from degradation.  However, when less Zrg17p protein is present in 
high zinc, less complex can be formed, and more Msc2p would be available for 
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degradation.  This model could be tested by examining Msc2p protein levels in a 
zrg17 mutant.  The prediction here would be that Msc2p protein levels would be 
lower in low zinc and would be similar to protein levels in high zinc since Zrg17p 
is not present.  The Zrg17p-independent model implies that some other change 
occurs between low zinc and high zinc that makes Msc2p more susceptible to 
degradation, such as the activation of a protease in high zinc.  If this second 
model were true, Msc2p protein levels would still be regulated by zinc in a zrg17 
mutant. 
A different reason for the zinc regulation of Msc2p could be due to the HA 
tags present on the C-terminus of the protein, i.e., the HA tags somehow make 
the protein more likely to be degraded in high zinc.  To address this possibility, 
we could determine the protein levels of a different tagged construct of Msc2p, 
such as a myc-tagged version, in low and high zinc and see if we get the same 
results as with the HA-tagged version.  We could also try an N-terminal tagged 
construct in case the position of the tag on the protein affects its zinc regulation.  
The best test would be to generate an antibody against the Msc2p protein itself, 
and then look at protein levels in low and high zinc, so as to not have to deal with 
a tagged protein at all. 
 
Reasons for the YPGE 37oC growth defect of msc2 and zrg17 mutants 
 Perhaps the most interesting phenotype of the msc2 and zrg17 mutants is 
their 37oC growth defect on glycerol-ethanol medium.  These mutants grow 
normally on glucose plates at 37oC, as well as on glycerol-ethanol plates at 30oC.  
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These results suggest that under normal growth conditions, the mitochondria in 
these mutants can respire normally.  Since Msc2p and Zrg17p localize to the ER 
instead of to the inner mitochondrial membrane, the reason for a possible 
respiratory defect of these mutants at 37oC is unclear. 
 It may be possible that the msc2 and zrg17 mutants have a temperature 
sensitive phenotype that disrupts mitochondrial respiration.  To test this, we could 
isolate mitochondria from wild type, msc2, zrg17, and/or msc2 zrg17 mutant cells 
grown in glycerol-ethanol medium at 30oC, where respiration is still normal.  
These mitochondria could then be tested for their respiratory capability using an 
oxygen electrode, which can measure oxygen consumption by the mitochondria.  
The chamber housing the mitochondria in the electrode can be controlled for 
temperature, so we could determine the effect of raising the temperature to 37oC 
on mitochondrial respiration.  A similar experiment would be to look at the oxygen 
consumption of mitochondria isolated from msc2 and zrg17 mutants that have 
been growing in glycerol-ethanol medium at 30oC and then shifted to 37oC for 
different lengths of time.  If the mitochondria from the mutants have a 
temperature sensitive respiratory defect, the oxygen consumption at 37oC should 
be greatly diminished relative to wild type mitochondria.  However, if the 
mitochondria from msc2 and zrg17 mutants can respire normally, regardless of 
temperature, then we should not see differences in oxygen consumption between 
these mitochondria and mitochondria from wild type cells.  If no differences are 
seen in mitochondrial respiration between the mutants and wild type cells, this 
suggests that the reason for the mutant 37oC growth defect may merely be due 
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to the combined stresses of heat and respiration (i.e., sub-optimal carbon 
sources), despite the medium being replete for zinc. 
 Alternatively, there could be an interesting correlation between the large 
cell phenotype and the 37oC growth defect.  The msc2 mutant was found to have 
a greater population of large cells in YPGE medium grown at 37oC than at 30oC 
(18).  We have postulated previously that an msc2 mutant may be defective in 
processes involving the attachment or secretion of proteins to the cell wall, 
including glycosylphosphatidylinositol- (GPI-) anchor synthesis (13).  Therefore, 
on YPGE at 37oC, with the additional stresses of heat and slower growth due to 
respiration, an msc2 mutant may not be able to maintain the integrity of its cell 
wall and limit its cell size, resulting in the large cell phenotype.  We have found 
that when we isolated large cells and placed them on YPD plates, no colonies 
formed, indicating these large cells are actually dead (D. Eide, unpublished 
observation).  This suggests that perhaps the formation of the large cell 
phenotype leads to cell death, and hence the 37oC growth defect.  Consistent 
with this hypothesis is our observation that the Hsp150p protein, which is found 
on the cell wall, suppresses the msc2 and zrg17 growth defect (Figure 3.1) and 
the msc2 mutant large cell phenotype (data not shown) when overexpressed.  
This suggests that overexpression of Hsp150p helps stabilize the cell wall so that 
the mutants can retain their normal cell size at 37oC and therefore survive at this 
higher temperature.  Similarly, with enough added zinc in the plates, the defects 
in the ER/secretory pathway caused by the absence of Msc2p/Zrg17p can be 
bypassed, and therefore the cells do not become large and die. 
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 To determine if there are cell wall defects in msc2 and zrg17 mutants, the 
integrity of their cell walls can be tested by their sensitivity to the drug calcofluor 
white.  Calcofluor white binds chitin in the cell wall and disrupts cell wall 
biogenesis (19, 20).  If cell wall integrity is compromised, the mutants should be 
more sensitive to calcofluor white than wild type cells.  The strains could be 
grown on different carbon sources, at different temperatures, and on plates 
containing different concentrations of zinc to determine the specific stress 
conditions that may result in compromised cell wall integrity and sensitivity to 
calcofluor white.  These results may tell us if the large cell phenotype and/or the 
37oC growth defect are related to weaknesses in the cell walls of the mutants. 
 
Other zinc transporters in the secretory pathway 
Since an msc2 zrg17 mutant is viable and its phenotypes are suppressible 
by zinc, there must be other zinc transporters in the ER and/or the secretory 
pathway that supply zinc to these compartments.  We have found that Zrc1p and 
Cot1p aid in zinc transport into the ER, as determined by the elevated UPR 
induction of a msc2 zrc1 cot1 triple mutant in low zinc (13).  However, even this 
triple mutant was suppressed by zinc. 
There are several approaches we could use to identify other zinc 
transporters in the secretory pathway.  Of particular interest would be to identify a 
zinc transporter in the Golgi apparatus, as none have yet been discovered in 
yeast.  One method is to identify candidate genes from the yeast genome 
sequence.  Some examples include the following proteins, all of which are P-type 
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ATPases that have been implicated with metal ion transport, but whose functions 
are not well-defined.  Cod1p/Spf1p has been localized to the ER, and a cod1 
mutant up-regulates the UPR.  Cod1p has been implicated with calcium 
homeostasis, but the actual ionic substrate of Cod1p is unknown (21).  Pca1p, 
whose localization is unknown, was suggested to be a copper transporter, 
whereas a mutant allele of Pca1p, called Cad2p, was implicated with cadmium 
tolerance (22, 23).  A final example is Pmr1p, which may be involved in 
transporting manganese and calcium into the Golgi (24, 25). 
A second method would be to use a transposon genetic screen in an 
msc2 zrg17 zrc1 cot1 mutant to identify other zinc transporters in the secretory 
pathway.  (Presumably this quadruple mutant would be viable since an msc2 
zrc1 cot1 mutant and an msc2 zrg17 mutant are both viable.)  If a transposon 
disrupts a gene encoding another zinc transporter essential for the function of the 
secretory pathway, we could screen for it in several ways.  One screen would be 
to look for transposon-insertion mutations that caused a synthetic lethal 
phenotype in the quadruple mutant on YPD at 37oC.  A second screen would 
look for mutations that exhibit the 37oC growth defect on YPGE and cannot be 
suppressed by zinc. 
However, if the transposon-insertions do not yield any informative 
mutations (possibly indicating the strains we would be interested in are not viable 
under normal growth conditions), we could do a suppressor screen.  While we 
have previously done a suppressor screen where we identified HSP150 as a 
suppressor of the msc2 mutant 37oC growth defect, this screen was not 
146 
exhaustive, and would be worth doing again in terms of an msc2 zrg17 zrc1 cot1 
mutant.  A different suppressor screen could look for genes that when 
overexpressed suppressed the zinc-deficient phenotype(s) of an msc2 zrg17 
zrc1 cot1 mutant, such as the UPR induction in low zinc. 
 
A mammalian zinc transport complex 
While we present novel evidence here of the interaction between two 
different CDF family members in yeast, this may actually be a common 
phenomenon with CDF members.  The closest mammalian homologue to Msc2p 
is ZnT5, and the closest mammalian homologue to Zrg17p is ZnT6.  Previous 
studies looked at the effects of overexpression of ZnT5 or ZnT6 on yeast growth; 
however, the results from these experiments were unclear as to the function of 
these genes in yeast (12, 26).  We found that the overexpression of both ZnT5 
and ZnT6 can suppress the 37oC growth phenotype of the msc2, zrg17, and 
msc2 zrg17 mutants (Figure 3.8).  This suppression only took place when both 
ZnT5 and ZnT6 were expressed in the same cell, regardless of zinc availability in 
the medium.  (The mammalian proteins must not be able to interact with the 
yeast proteins or function independently in yeast.)  This suggests that ZnT5 and 
ZnT6 interact in yeast to form a complex that can transport zinc into the secretory 
pathway. 
These results also suggest that ZnT5 and ZnT6 have the potential to form 
a complex in mammalian cells.  Supporting this hypothesis, in mammalian cells 
ZnT5 and ZnT6 are both expressed in the Golgi apparatus (12, 26) and in many 
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of the same tissues, as determined by EST database mining (27).  This 
mammalian complex also has the potential to be regulated by zinc.  ZnT5 mRNA 
was shown to be up-regulated by TPEN treatment (or zinc deficiency) in 
mammalian cells (28), similar to the zinc regulation of ZRG17 in yeast. 
However, ZnT5 and ZnT6 are also expressed in tissues where the other is 
not (27).  This might mean several things.  First, ZnT5 and ZnT6 might interact 
with other ZnTs.  For example, both ZnT5 and ZnT8 are highly expressed in 
pancreas (12, 27, 29), suggesting that perhaps the proteins of these two genes 
interact in beta cells to supply zinc for insulin granule formation.  Also, ZnT6 
might interact with ZnT7, which is the closest mammalian homologue to ZnT5 
(27), and is also up-regulated by zinc deficiency (28).  Alternatively, it is possible 
that ZnT5 and ZnT6 are indeed expressed in all the same tissues, but the 
methods used to determine expression levels so far (Northerns, EST database 
mining) have not been sensitive enough to determine this.  Second, ZnT5 and 
ZnT6 might be able to have some individual transport activity.  If so, this might 
suggest that there would be some advantage to having them interact as a 
complex, or that the individual activity of the transporters would be greatly 
enhanced when both ZnT5 and ZnT6 are present.  ZnT5 was shown to have 
transport ability in Golgi vesicles isolated from HeLa cells (12).  ZnT6 might also 
have been expressed endogenously in these cells, so that the transport activity 
seen was actually that of the complex and not of ZnT5 alone. 
The exact function of ZnT5 and ZnT6 in transporting zinc into the Golgi in 
mammalian cells is unknown.  However, a recent report has suggested ZnT5 is 
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needed to supply zinc to GPI-anchored alkaline phosphatases, which transit 
through the secretory pathway to the plasma membrane (30).  Since ZnT5 and 
ZnT6 can complement the 37oC growth defect of the msc2 and zrg17 mutants 
(Figure 3.8), this suggests that perhaps ZnT5 and ZnT6 perform the same 
function as Msc2p and Zrg17p:  supplying zinc to the secretory pathway to 
maintain protein folding in the ER and other processes.  To test this, we could 
introduce our UPRE-lacZ reporter in the msc2 and zrg17 mutant strains 
expressing ZnT5 and ZnT6 and determine if the mammalian proteins can 
suppress the induction of the UPR in low zinc.  Another test would be to knock 
down ZnT5 and/or ZnT6 transcript levels in mammalian cells (through antisense 
oligonucleotide- or RNAi-mediated mRNA degradation) and look for an induction 
in the activity of our mammalian ER stress response luciferase reporter.  Both of 
these assays would look at the functional significance of ZnT5 and ZnT6 in the 
secretory pathway. 
 
Summary 
We present here novel evidence that two CDF family members, Msc2p 
and Zrg17p, interact to form a complex in the ER membrane.  The purpose of 
this complex is to transport zinc into the ER to maintain proper ER function.  This 
includes maintaining protein folding and protein degradation systems in the ER.  
While Zrc1p and Cot1p aid in supplying zinc to the ER, other zinc transporters in 
the secretory pathway are yet to be found.  The results found in yeast are 
reflected in mammalian cells.  Mammalian cells also require zinc for protein 
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folding in the ER.  Analogous to Msc2p and Zrg17p, the ZnT5 and ZnT6 proteins 
may potentially interact to form a zinc transport complex in the secretory pathway 
in mammalian cells.  These results suggest that there is a universal requirement 
for zinc in the function of the ER, and that the interaction between different CDF 
family members may be a widely seen phenomenon.
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